AXA/2025/FY financial supplements: Difference between revisions
Appearance
< AXA
Content deleted Content added
PlumBot: re-publish AXA FY2025 financial supplement (rendering fixes: number format, units, captions, empty-column cleanup, footnotes) |
PlumBot: re-publish AXA FY2025 financial supplement (house-style widths, bracketed * footnotes, collapsed duplicate headers) |
||
| Line 3: | Line 3: | ||
== 1. Market Data == |
== 1. Market Data == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Exchange Rate |
|+ Exchange Rate |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | Average 1H24 |
! style="text-align:right; width:6em" | Average 1H24 |
||
! style="text-align:right" | Average FY24 |
! style="text-align:right; width:6em" | Average FY24 |
||
! style="text-align:right" | Average 1H25 |
! style="text-align:right; width:6em" | Average 1H25 |
||
! style="text-align:right" | Average FY25 |
! style="text-align:right; width:6em" | Average FY25 |
||
|- |
|- |
||
| style="text-align:left" | USD |
| style="text-align:left" | USD |
||
| Line 65: | Line 66: | ||
| style="text-align:right" | 8.82 |
| style="text-align:right" | 8.82 |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Discount Rate - 5Y |
|+ Discount Rate - 5Y |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | Average 1H24 |
! style="text-align:right; width:6em" | Average 1H24 |
||
! style="text-align:right" | Average FY24 |
! style="text-align:right; width:6em" | Average FY24 |
||
! style="text-align:right" | Average 1H25 |
! style="text-align:right; width:6em" | Average 1H25 |
||
! style="text-align:right" | Average FY25 |
! style="text-align:right; width:6em" | Average FY25 |
||
|- |
|- |
||
| style="text-align:left" | EUR |
| style="text-align:left" | EUR |
||
| Line 110: | Line 113: | ||
| style="text-align:right" | 3.18% |
| style="text-align:right" | 3.18% |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Discount Rate - 10Y |
|+ Discount Rate - 10Y |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | Closing 1H24 |
! style="text-align:right; width:6em" | Closing 1H24 |
||
! style="text-align:right" | Closing FY24 |
! style="text-align:right; width:6em" | Closing FY24 |
||
! style="text-align:right" | Closing 1H25 |
! style="text-align:right; width:6em" | Closing 1H25 |
||
! style="text-align:right" | Closing FY25 |
! style="text-align:right; width:6em" | Closing FY25 |
||
|- |
|- |
||
| style="text-align:left" | EUR |
| style="text-align:left" | EUR |
||
| Line 155: | Line 160: | ||
| style="text-align:right" | 3.21% |
| style="text-align:right" | 3.21% |
||
|} |
|} |
||
</div> |
|||
== 2. UE by LOB and Net Income == |
== 2. UE by LOB and Net Income == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Group Underlying Earnings by Line of Business and Net Income |
|+ Group Underlying Earnings by Line of Business and Net Income |
||
| Line 168: | Line 175: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Short-term Business''' |
| style="text-align:left" | '''Short-term Business''' |
||
| Line 805: | Line 812: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
|||
* |
* (*) AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025. |
||
* |
* (**) Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25. |
||
== 3. UE by Geography == |
== 3. UE by Geography == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Underlying Earnings by Geography |
|+ Underlying Earnings by Geography |
||
| Line 823: | Line 832: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Short-term Business''' |
| style="text-align:left" | '''Short-term Business''' |
||
| Line 1,362: | Line 1,371: | ||
| style="text-align:right" | '''-903''' |
| style="text-align:right" | '''-903''' |
||
|} |
|} |
||
</div> |
|||
* |
* (*) AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025. |
||
* |
* (**) Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25. |
||
== 4. Shares & UEPS == |
== 4. Shares & UEPS == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,374: | Line 1,385: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Basic Number of Shares''' |
| style="text-align:left" | '''Basic Number of Shares''' |
||
| Line 1,517: | Line 1,528: | ||
| style="text-align:right" | 3.86 |
| style="text-align:right" | 3.86 |
||
|} |
|} |
||
</div> |
|||
* <sup>(a)</sup> Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24. |
* <sup>(a)</sup> Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24. |
||
| Line 1,522: | Line 1,534: | ||
== 5. P&C UE by Sub LOB == |
== 5. P&C UE by Sub LOB == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Property & Casualty Underlying Earnings by Line of Business |
|+ Property & Casualty Underlying Earnings by Line of Business |
||
| Line 1,532: | Line 1,545: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Short-term Business''' |
| style="text-align:left" | '''Short-term Business''' |
||
| Line 2,235: | Line 2,248: | ||
| style="text-align:right" | '''-35''' |
| style="text-align:right" | '''-35''' |
||
|} |
|} |
||
</div> |
|||
* For long-term business |
* For long-term business |
||
| Line 2,241: | Line 2,255: | ||
== 6. P&C UE by Geography == |
== 6. P&C UE by Geography == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Property & Casualty Underlying Earnings by Geography |
|+ Property & Casualty Underlying Earnings by Geography |
||
| Line 2,250: | Line 2,265: | ||
! colspan="4" style="text-align:center" | Asia, Africa & EME-LATAM |
! colspan="4" style="text-align:center" | Asia, Africa & EME-LATAM |
||
! colspan="4" style="text-align:center" | Transversal & Other |
! colspan="4" style="text-align:center" | Transversal & Other |
||
|- |
|||
! style="text-align:left" | |
|||
! style="text-align:center" | 1H24 |
|||
! style="text-align:center" | FY24 |
|||
! style="text-align:center" | 1H25 |
|||
! style="text-align:center" | FY25 |
|||
! style="text-align:center" | 1H24 |
|||
! style="text-align:center" | FY24 |
|||
! style="text-align:center" | 1H25 |
|||
! style="text-align:center" | FY25 |
|||
! style="text-align:center" | 1H24 |
|||
! style="text-align:center" | FY24 |
|||
! style="text-align:center" | 1H25 |
|||
! style="text-align:center" | FY25 |
|||
! style="text-align:center" | 1H24 |
|||
! style="text-align:center" | o/w AXA XL Insurance |
|||
! style="text-align:center" | FY24 |
|||
! style="text-align:center" | o/w AXA XL Insurance |
|||
! style="text-align:center" | 1H25 |
|||
! style="text-align:center" | o/w AXA XL Insurance |
|||
! style="text-align:center" | FY25 |
|||
! style="text-align:center" | o/w AXA XL Insurance |
|||
! style="text-align:center" | 1H24 |
|||
! style="text-align:center" | FY24 |
|||
! style="text-align:center" | 1H25 |
|||
! style="text-align:center" | FY25 |
|||
! style="text-align:center" | 1H24 |
|||
! style="text-align:center" | FY24 |
|||
! style="text-align:center" | 1H25 |
|||
! style="text-align:center" | FY25 |
|||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | o/w AXA XL Insurance |
! style="text-align:right; width:6em" | o/w AXA XL Insurance |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | o/w AXA XL Insurance |
! style="text-align:right; width:6em" | o/w AXA XL Insurance |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | o/w AXA XL Insurance |
! style="text-align:right; width:6em" | o/w AXA XL Insurance |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | o/w AXA XL Insurance |
! style="text-align:right; width:6em" | o/w AXA XL Insurance |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Short-term Business''' |
| style="text-align:left" | '''Short-term Business''' |
||
| Line 3,151: | Line 3,136: | ||
| style="text-align:right" | '''2,101''' |
| style="text-align:right" | '''2,101''' |
||
|} |
|} |
||
</div> |
|||
* For long-term business |
* For long-term business |
||
| Line 3,157: | Line 3,143: | ||
== 7. L&H UE by LOB == |
== 7. L&H UE by LOB == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Life & Health Underlying Earnings by Line of Business |
|+ Life & Health Underlying Earnings by Line of Business |
||
| Line 3,166: | Line 3,153: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Short-term Business''' |
| style="text-align:left" | '''Short-term Business''' |
||
| Line 3,795: | Line 3,782: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
|||
* |
* (*) Employee Benefits include Group Protection and Group Health contracts. |
||
== 8. L&H UE by Geography == |
== 8. L&H UE by Geography == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Life & Health Underlying Earnings by Geography |
|+ Life & Health Underlying Earnings by Geography |
||
| Line 3,811: | Line 3,800: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Short-term Business''' |
| style="text-align:left" | '''Short-term Business''' |
||
| Line 4,642: | Line 4,631: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|} |
|} |
||
</div> |
|||
== 9. Life UE by Geography == |
== 9. Life UE by Geography == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Life Underlying Earnings by Geography |
|+ Life Underlying Earnings by Geography |
||
| Line 4,656: | Line 4,647: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Short-term Business''' |
| style="text-align:left" | '''Short-term Business''' |
||
| Line 5,487: | Line 5,478: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|} |
|} |
||
</div> |
|||
== 10. Health UE by Geography == |
== 10. Health UE by Geography == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Health Underlying Earnings by Geography |
|+ Health Underlying Earnings by Geography |
||
| Line 5,501: | Line 5,494: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Short-term Business''' |
| style="text-align:left" | '''Short-term Business''' |
||
| Line 6,332: | Line 6,325: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|} |
|} |
||
</div> |
|||
== 11. Asset Management == |
== 11. Asset Management == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
| Line 6,343: | Line 6,338: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | o/w Third Party |
! style="text-align:right; width:6em" | o/w Third Party |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | o/w Third Party |
! style="text-align:right; width:6em" | o/w Third Party |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | o/w Third Party |
! style="text-align:right; width:6em" | o/w Third Party |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | o/w Third Party |
! style="text-align:right; width:6em" | o/w Third Party |
||
|- |
|- |
||
| style="text-align:left" | '''Opening AUM (in Euro billion)''' |
| style="text-align:left" | '''Opening AUM (in Euro billion)''' |
||
| Line 6,612: | Line 6,607: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
|||
* |
* (*) AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025. |
||
== 12. Holdings == |
== 12. Holdings == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Holdings Underlying Earnings¹ |
|+ Holdings Underlying Earnings¹ |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:right" | 1H24 |
! style="text-align:right; width:6em" | 1H24 |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | 1H25 |
! style="text-align:right; width:6em" | 1H25 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Financial Result |
| style="text-align:left" | Financial Result |
||
| Line 6,679: | Line 6,676: | ||
| style="text-align:right" | '''-1,180''' |
| style="text-align:right" | '''-1,180''' |
||
|} |
|} |
||
</div> |
|||
* <sup>¹</sup> Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25. |
* <sup>¹</sup> Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25. |
||
| Line 6,687: | Line 6,685: | ||
== 13. Activity indicators == |
== 13. Activity indicators == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Activity Indicators by Line of Business |
|+ Activity Indicators by Line of Business |
||
| Line 6,696: | Line 6,695: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | P&C |
! style="text-align:right; width:6em" | P&C |
||
! style="text-align:right" | Life & Health |
! style="text-align:right; width:6em" | Life & Health |
||
! style="text-align:right" | o/w Employee Benefits |
! style="text-align:right; width:6em" | o/w Employee Benefits |
||
! style="text-align:right" | Life |
! style="text-align:right; width:6em" | Life |
||
! style="text-align:right" | Health |
! style="text-align:right; width:6em" | Health |
||
! style="text-align:right" | Asset Management |
! style="text-align:right; width:6em" | Asset Management |
||
! style="text-align:right" | Bank |
! style="text-align:right; width:6em" | Bank |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | P&C |
! style="text-align:right; width:6em" | P&C |
||
! style="text-align:right" | Life & Health |
! style="text-align:right; width:6em" | Life & Health |
||
! style="text-align:right" | o/w Employee Benefits |
! style="text-align:right; width:6em" | o/w Employee Benefits |
||
! style="text-align:right" | Life |
! style="text-align:right; width:6em" | Life |
||
! style="text-align:right" | Health |
! style="text-align:right; width:6em" | Health |
||
! style="text-align:right" | Asset Management |
! style="text-align:right; width:6em" | Asset Management |
||
! style="text-align:right" | Bank |
! style="text-align:right; width:6em" | Bank |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | P&C |
! style="text-align:right; width:6em" | P&C |
||
! style="text-align:right" | Life & Health |
! style="text-align:right; width:6em" | Life & Health |
||
! style="text-align:right" | o/w Employee Benefits |
! style="text-align:right; width:6em" | o/w Employee Benefits |
||
! style="text-align:right" | Life |
! style="text-align:right; width:6em" | Life |
||
! style="text-align:right" | Health |
! style="text-align:right; width:6em" | Health |
||
! style="text-align:right" | Asset Management |
! style="text-align:right; width:6em" | Asset Management |
||
! style="text-align:right" | Bank |
! style="text-align:right; width:6em" | Bank |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | P&C |
! style="text-align:right; width:6em" | P&C |
||
! style="text-align:right" | Life & Health |
! style="text-align:right; width:6em" | Life & Health |
||
! style="text-align:right" | o/w Employee Benefits |
! style="text-align:right; width:6em" | o/w Employee Benefits |
||
! style="text-align:right" | Life |
! style="text-align:right; width:6em" | Life |
||
! style="text-align:right" | Health |
! style="text-align:right; width:6em" | Health |
||
! style="text-align:right" | Asset Management |
! style="text-align:right; width:6em" | Asset Management |
||
! style="text-align:right" | Bank |
! style="text-align:right; width:6em" | Bank |
||
|- |
|- |
||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
| style="text-align:left" | Gross Written Premiums & Other Revenues |
||
| Line 6,967: | Line 6,966: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Activity Indicators by Geography |
|+ Activity Indicators by Geography |
||
| Line 6,977: | Line 6,978: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | France |
! style="text-align:right; width:6em" | France |
||
! style="text-align:right" | Europe |
! style="text-align:right; width:6em" | Europe |
||
! style="text-align:right" | AXA XL |
! style="text-align:right; width:6em" | AXA XL |
||
! style="text-align:right" | Asia, Africa & EME-LATAM |
! style="text-align:right; width:6em" | Asia, Africa & EME-LATAM |
||
! style="text-align:right" | AXA IM |
! style="text-align:right; width:6em" | AXA IM |
||
! style="text-align:right" | Transversal & Other |
! style="text-align:right; width:6em" | Transversal & Other |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | France |
! style="text-align:right; width:6em" | France |
||
! style="text-align:right" | Europe |
! style="text-align:right; width:6em" | Europe |
||
! style="text-align:right" | AXA XL |
! style="text-align:right; width:6em" | AXA XL |
||
! style="text-align:right" | Asia, Africa & EME-LATAM |
! style="text-align:right; width:6em" | Asia, Africa & EME-LATAM |
||
! style="text-align:right" | AXA IM |
! style="text-align:right; width:6em" | AXA IM |
||
! style="text-align:right" | Transversal & Other |
! style="text-align:right; width:6em" | Transversal & Other |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | France |
! style="text-align:right; width:6em" | France |
||
! style="text-align:right" | Europe |
! style="text-align:right; width:6em" | Europe |
||
! style="text-align:right" | AXA XL |
! style="text-align:right; width:6em" | AXA XL |
||
! style="text-align:right" | Asia, Africa & EME-LATAM |
! style="text-align:right; width:6em" | Asia, Africa & EME-LATAM |
||
! style="text-align:right" | AXA IM |
! style="text-align:right; width:6em" | AXA IM |
||
! style="text-align:right" | Transversal & Other |
! style="text-align:right; width:6em" | Transversal & Other |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | France |
! style="text-align:right; width:6em" | France |
||
! style="text-align:right" | Europe |
! style="text-align:right; width:6em" | Europe |
||
! style="text-align:right" | AXA XL |
! style="text-align:right; width:6em" | AXA XL |
||
! style="text-align:right" | Asia, Africa & EME-LATAM |
! style="text-align:right; width:6em" | Asia, Africa & EME-LATAM |
||
! style="text-align:right" | AXA IM |
! style="text-align:right; width:6em" | AXA IM |
||
! style="text-align:right" | Transversal & Other |
! style="text-align:right; width:6em" | Transversal & Other |
||
|- |
|- |
||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
| style="text-align:left" | Gross Written Premiums & Other Revenues |
||
| Line 7,216: | Line 7,217: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
|||
* |
* (*) Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers. |
||
* |
* (**) Employee Benefits include Group Protection and Group Health contracts. |
||
== 14. Balance Sheet == |
== 14. Balance Sheet == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Assets |
|+ Assets |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Goodwill |
| style="text-align:left" | Goodwill |
||
| Line 7,296: | Line 7,299: | ||
| style="text-align:right" | '''635.5''' |
| style="text-align:right" | '''635.5''' |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Liabilities, Non-controlling Interests & Shareholders' Equity |
|+ Liabilities, Non-controlling Interests & Shareholders' Equity |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Shareholders' Equity group share |
| style="text-align:left" | Shareholders' Equity group share |
||
| Line 7,363: | Line 7,368: | ||
| style="text-align:right" | '''635.5''' |
| style="text-align:right" | '''635.5''' |
||
|} |
|} |
||
</div> |
|||
== 15.CSM Rollforward == |
== 15.CSM Rollforward == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Contractual Service Margin (CSM) |
|+ Contractual Service Margin (CSM) |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:right" | FY23 Restated |
! style="text-align:right; width:6em" | FY23 Restated |
||
! style="text-align:right" | New Business CSM |
! style="text-align:right; width:6em" | New Business CSM |
||
! style="text-align:right" | Underlying Return on inforce |
! style="text-align:right; width:6em" | Underlying Return on inforce |
||
! style="text-align:right" | CSM Release |
! style="text-align:right; width:6em" | CSM Release |
||
! style="text-align:right" | Economic Variance |
! style="text-align:right; width:6em" | Economic Variance |
||
! style="text-align:right" | Operating Variance |
! style="text-align:right; width:6em" | Operating Variance |
||
! style="text-align:right" | Other* |
! style="text-align:right; width:6em" | Other* |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
|- |
|- |
||
| style="text-align:left" | '''Total Group (pre-tax)''' |
| style="text-align:left" | '''Total Group (pre-tax)''' |
||
| Line 7,428: | Line 7,435: | ||
| style="text-align:right" | '''26,320''' |
| style="text-align:right" | '''26,320''' |
||
|} |
|} |
||
</div> |
|||
* |
* (*) Including scope changes and FX. ** Following the termination of the sale of a closed life and pensions portfolio at AXA Germany in 2024. It was classified as held for sale in 2023. |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Contractual Service Margin (CSM) |
|+ Contractual Service Margin (CSM) |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | New Business CSM |
! style="text-align:right; width:6em" | New Business CSM |
||
! style="text-align:right" | Underlying Return on inforce |
! style="text-align:right; width:6em" | Underlying Return on inforce |
||
! style="text-align:right" | CSM Release |
! style="text-align:right; width:6em" | CSM Release |
||
! style="text-align:right" | Economic Variance |
! style="text-align:right; width:6em" | Economic Variance |
||
! style="text-align:right" | Operating Variance |
! style="text-align:right; width:6em" | Operating Variance |
||
! style="text-align:right" | Other* |
! style="text-align:right; width:6em" | Other* |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Total Group (pre-tax)''' |
| style="text-align:left" | '''Total Group (pre-tax)''' |
||
| Line 7,493: | Line 7,502: | ||
| style="text-align:right" | '''25,864''' |
| style="text-align:right" | '''25,864''' |
||
|} |
|} |
||
</div> |
|||
* |
* (*) Including scope changes and FX. |
||
== 16. Invested Assets == |
== 16. Invested Assets == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ General Account Invested Assets as of FY25 |
|+ General Account Invested Assets as of FY25 |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align: |
! style="text-align:right; width:6em" | Fair value |
||
! style="text-align: |
! style="text-align:right; width:6em" | Asset Allocation % |
||
! style="text-align: |
! style="text-align:right; width:6em" | o/w Participating |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:right" | Fair value |
|||
! style="text-align:right" | Asset Allocation % |
|||
! style="text-align:right" | o/w Participating |
|||
|- |
|- |
||
| style="text-align:left" | '''General Account Invested Assets1''' |
| style="text-align:left" | '''General Account Invested Assets1''' |
||
| Line 7,575: | Line 7,581: | ||
| style="text-align:right" | 51% |
| style="text-align:right" | 51% |
||
|} |
|} |
||
</div> |
|||
* 1 Reflects the fair value of assets excluding the minority interest share in assets held in fully consolidated invested funds, hedging derivatives, Unit-linked assets and investments from non-insurance activities. |
* 1 Reflects the fair value of assets excluding the minority interest share in assets held in fully consolidated invested funds, hedging derivatives, Unit-linked assets and investments from non-insurance activities. |
||
| Line 7,583: | Line 7,590: | ||
* 5 Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion). |
* 5 Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion). |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Duration gap |
|+ Duration gap |
||
| Line 7,589: | Line 7,597: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | Average rating |
! style="text-align:right; width:6em" | Average rating |
||
! style="text-align:right" | AAA |
! style="text-align:right; width:6em" | AAA |
||
! style="text-align:right" | AA |
! style="text-align:right; width:6em" | AA |
||
! style="text-align:right" | A |
! style="text-align:right; width:6em" | A |
||
! style="text-align:right" | BBB |
! style="text-align:right; width:6em" | BBB |
||
! style="text-align:right" | Below Investment Grade |
! style="text-align:right; width:6em" | Below Investment Grade |
||
! style="text-align:right" | Non Rated |
! style="text-align:right; width:6em" | Non Rated |
||
|- |
|- |
||
| style="text-align:left" | '''-0.4 yr''' |
| style="text-align:left" | '''-0.4 yr''' |
||
| Line 7,633: | Line 7,641: | ||
| style="text-align:right" | 4% |
| style="text-align:right" | 4% |
||
|} |
|} |
||
</div> |
|||
== 17. Supplementary Info on Asset == |
== 17. Supplementary Info on Asset == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Breakdown By Geographical Exposure |
|+ Breakdown By Geographical Exposure |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Fair Value |
! style="text-align:right; width:6em" | Fair Value |
||
! style="text-align:right" | Belgium |
! style="text-align:right; width:6em" | Belgium |
||
! style="text-align:right" | France |
! style="text-align:right; width:6em" | France |
||
! style="text-align:right" | Germany |
! style="text-align:right; width:6em" | Germany |
||
! style="text-align:right" | Italy |
! style="text-align:right; width:6em" | Italy |
||
! style="text-align:right" | Japan |
! style="text-align:right; width:6em" | Japan |
||
! style="text-align:right" | Netherlands |
! style="text-align:right; width:6em" | Netherlands |
||
! style="text-align:right" | Spain |
! style="text-align:right; width:6em" | Spain |
||
! style="text-align:right" | Switzerland |
! style="text-align:right; width:6em" | Switzerland |
||
! style="text-align:right" | United States |
! style="text-align:right; width:6em" | United States |
||
! style="text-align:right" | Other EU countries |
! style="text-align:right; width:6em" | Other EU countries |
||
! style="text-align:right" | Supranational |
! style="text-align:right; width:6em" | Supranational |
||
! style="text-align:right" | Rest of the World |
! style="text-align:right; width:6em" | Rest of the World |
||
|- |
|- |
||
| style="text-align:left" | Breakdown By Geographical Exposure |
| style="text-align:left" | Breakdown By Geographical Exposure |
||
| Line 7,668: | Line 7,678: | ||
| style="text-align:right" | 15% |
| style="text-align:right" | 15% |
||
|} |
|} |
||
</div> |
|||
* Corporate Bonds and Loans |
* Corporate Bonds and Loans |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Breakdown By Industry |
|+ Breakdown By Industry |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Fair Value |
! style="text-align:right; width:6em" | Fair Value |
||
! style="text-align:right" | Basic Materials |
! style="text-align:right; width:6em" | Basic Materials |
||
! style="text-align:right" | Communications |
! style="text-align:right; width:6em" | Communications |
||
! style="text-align:right" | Consumer, Cyclical |
! style="text-align:right; width:6em" | Consumer, Cyclical |
||
! style="text-align:right" | Consumer, Non-Cyclical |
! style="text-align:right; width:6em" | Consumer, Non-Cyclical |
||
! style="text-align:right" | Covered and Senior Secured Bonds |
! style="text-align:right; width:6em" | Covered and Senior Secured Bonds |
||
! style="text-align:right" | Energy |
! style="text-align:right; width:6em" | Energy |
||
! style="text-align:right" | Financials |
! style="text-align:right; width:6em" | Financials |
||
! style="text-align:right" | Industrial |
! style="text-align:right; width:6em" | Industrial |
||
! style="text-align:right" | Technology |
! style="text-align:right; width:6em" | Technology |
||
! style="text-align:right" | Utilities |
! style="text-align:right; width:6em" | Utilities |
||
! style="text-align:right" | Other |
! style="text-align:right; width:6em" | Other |
||
|- |
|- |
||
| style="text-align:left" | Breakdown By Industry |
| style="text-align:left" | Breakdown By Industry |
||
| Line 7,701: | Line 7,713: | ||
| style="text-align:right" | 3% |
| style="text-align:right" | 3% |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Exposure to the Financials |
|+ Exposure to the Financials |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | Banks |
! style="text-align:right; width:6em" | Banks |
||
! style="text-align:right" | Non-Banks |
! style="text-align:right; width:6em" | Non-Banks |
||
|- |
|- |
||
| style="text-align:left" | '''Total''' |
| style="text-align:left" | '''Total''' |
||
| Line 7,729: | Line 7,743: | ||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
|} |
|} |
||
</div> |
|||
* 1 Includes REITS corporate bonds (Euro 3 billion). |
* 1 Includes REITS corporate bonds (Euro 3 billion). |
||
| Line 7,734: | Line 7,749: | ||
* Listed Equities1 |
* Listed Equities1 |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Breakdown By Asset Domiciliation |
|+ Breakdown By Asset Domiciliation |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Fair Value |
! style="text-align:right; width:6em" | Fair Value |
||
! style="text-align:right" | Belgium |
! style="text-align:right; width:6em" | Belgium |
||
! style="text-align:right" | France |
! style="text-align:right; width:6em" | France |
||
! style="text-align:right" | Germany |
! style="text-align:right; width:6em" | Germany |
||
! style="text-align:right" | Japan |
! style="text-align:right; width:6em" | Japan |
||
! style="text-align:right" | Netherlands |
! style="text-align:right; width:6em" | Netherlands |
||
! style="text-align:right" | Switzerland |
! style="text-align:right; width:6em" | Switzerland |
||
! style="text-align:right" | United States |
! style="text-align:right; width:6em" | United States |
||
! style="text-align:right" | Other EU countries |
! style="text-align:right; width:6em" | Other EU countries |
||
! style="text-align:right" | Rest of the World |
! style="text-align:right; width:6em" | Rest of the World |
||
|- |
|- |
||
| style="text-align:left" | Breakdown By Asset Domiciliation |
| style="text-align:left" | Breakdown By Asset Domiciliation |
||
| Line 7,760: | Line 7,776: | ||
| style="text-align:right" | 27% |
| style="text-align:right" | 27% |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Breakdown By Industry |
|+ Breakdown By Industry |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Fair Value |
! style="text-align:right; width:6em" | Fair Value |
||
! style="text-align:right" | Basic Materials |
! style="text-align:right; width:6em" | Basic Materials |
||
! style="text-align:right" | Communications |
! style="text-align:right; width:6em" | Communications |
||
! style="text-align:right" | Consumer, Cyclical |
! style="text-align:right; width:6em" | Consumer, Cyclical |
||
! style="text-align:right" | Consumer, Non-Cyclical |
! style="text-align:right; width:6em" | Consumer, Non-Cyclical |
||
! style="text-align:right" | Diversified |
! style="text-align:right; width:6em" | Diversified |
||
! style="text-align:right" | Energy |
! style="text-align:right; width:6em" | Energy |
||
! style="text-align:right" | Financials |
! style="text-align:right; width:6em" | Financials |
||
! style="text-align:right" | Funds |
! style="text-align:right; width:6em" | Funds |
||
! style="text-align:right" | Industrial |
! style="text-align:right; width:6em" | Industrial |
||
! style="text-align:right" | Technology |
! style="text-align:right; width:6em" | Technology |
||
! style="text-align:right" | Utilities |
! style="text-align:right; width:6em" | Utilities |
||
! style="text-align:right" | Other |
! style="text-align:right; width:6em" | Other |
||
|- |
|- |
||
| style="text-align:left" | Breakdown By Industry |
| style="text-align:left" | Breakdown By Industry |
||
| Line 7,793: | Line 7,811: | ||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
|} |
|} |
||
</div> |
|||
* 1 Including hedges. |
* 1 Including hedges. |
||
* Real Estate |
* Real Estate |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Breakdown By Geographical Exposure |
|+ Breakdown By Geographical Exposure |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Fair Value |
! style="text-align:right; width:6em" | Fair Value |
||
! style="text-align:right" | Belgium |
! style="text-align:right; width:6em" | Belgium |
||
! style="text-align:right" | France |
! style="text-align:right; width:6em" | France |
||
! style="text-align:right" | Germany |
! style="text-align:right; width:6em" | Germany |
||
! style="text-align:right" | Italy |
! style="text-align:right; width:6em" | Italy |
||
! style="text-align:right" | Japan |
! style="text-align:right; width:6em" | Japan |
||
! style="text-align:right" | Spain |
! style="text-align:right; width:6em" | Spain |
||
! style="text-align:right" | Switzerland |
! style="text-align:right; width:6em" | Switzerland |
||
! style="text-align:right" | United Kingdom |
! style="text-align:right; width:6em" | United Kingdom |
||
! style="text-align:right" | United States |
! style="text-align:right; width:6em" | United States |
||
! style="text-align:right" | Other EU countries |
! style="text-align:right; width:6em" | Other EU countries |
||
! style="text-align:right" | Rest of the World |
! style="text-align:right; width:6em" | Rest of the World |
||
|- |
|- |
||
| style="text-align:left" | Breakdown By Geographical Exposure |
| style="text-align:left" | Breakdown By Geographical Exposure |
||
| Line 7,827: | Line 7,847: | ||
| style="text-align:right" | 10% |
| style="text-align:right" | 10% |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Breakdown By Type |
|+ Breakdown By Type |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Fair Value |
! style="text-align:right; width:6em" | Fair Value |
||
! style="text-align:right" | Office |
! style="text-align:right; width:6em" | Office |
||
! style="text-align:right" | Residential |
! style="text-align:right; width:6em" | Residential |
||
! style="text-align:right" | Industrial-Logistic |
! style="text-align:right; width:6em" | Industrial-Logistic |
||
! style="text-align:right" | Retail |
! style="text-align:right; width:6em" | Retail |
||
! style="text-align:right" | Others |
! style="text-align:right; width:6em" | Others |
||
|- |
|- |
||
| style="text-align:left" | Breakdown By Type |
| style="text-align:left" | Breakdown By Type |
||
| Line 7,846: | Line 7,868: | ||
| style="text-align:right" | 18% |
| style="text-align:right" | 18% |
||
|} |
|} |
||
</div> |
|||
* Private Equities1 |
* Private Equities1 |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Breakdown By Asset Domiciliation |
|+ Breakdown By Asset Domiciliation |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Fair Value |
! style="text-align:right; width:6em" | Fair Value |
||
! style="text-align:right" | Europe |
! style="text-align:right; width:6em" | Europe |
||
! style="text-align:right" | Japan |
! style="text-align:right; width:6em" | Japan |
||
! style="text-align:right" | United States |
! style="text-align:right; width:6em" | United States |
||
! style="text-align:right" | Other |
! style="text-align:right; width:6em" | Other |
||
|- |
|- |
||
| style="text-align:left" | Breakdown By Asset Domiciliation |
| style="text-align:left" | Breakdown By Asset Domiciliation |
||
| Line 7,865: | Line 7,889: | ||
| style="text-align:right" | 5% |
| style="text-align:right" | 5% |
||
|} |
|} |
||
</div> |
|||
* 1 Excluding Non-listed Equity. |
* 1 Excluding Non-listed Equity. |
||
* Mortgage Loans1,2 |
* Mortgage Loans1,2 |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Breakdown by Type |
|+ Breakdown by Type |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Fair Value |
! style="text-align:right; width:6em" | Fair Value |
||
! style="text-align:right" | Residential |
! style="text-align:right; width:6em" | Residential |
||
! style="text-align:right" | Commercial |
! style="text-align:right; width:6em" | Commercial |
||
|- |
|- |
||
| style="text-align:left" | Breakdown by Type |
| style="text-align:left" | Breakdown by Type |
||
| Line 7,881: | Line 7,907: | ||
| style="text-align:right" | 31% |
| style="text-align:right" | 31% |
||
|} |
|} |
||
</div> |
|||
* 1 Excludes banking operations and Euro 8 billion of Agency pools (Mortgage-backed securities issues by US Government Sponsored Enterprises). |
* 1 Excludes banking operations and Euro 8 billion of Agency pools (Mortgage-backed securities issues by US Government Sponsored Enterprises). |
||
| Line 7,887: | Line 7,914: | ||
== 18. Shareholders Equity == |
== 18. Shareholders Equity == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Change in Group Share Consolidated Shareholders' Equity |
|+ Change in Group Share Consolidated Shareholders' Equity |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Shareholders' Equity at Beginning of the Period''' |
| style="text-align:left" | '''Shareholders' Equity at Beginning of the Period''' |
||
| Line 7,934: | Line 7,962: | ||
| style="text-align:right" | '''47.2''' |
| style="text-align:right" | '''47.2''' |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Group Share Consolidated Shareholders' Equity |
|+ Group Share Consolidated Shareholders' Equity |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Paid-in Capital |
| style="text-align:left" | Paid-in Capital |
||
| Line 7,981: | Line 8,011: | ||
| style="text-align:right" | '''47.2''' |
| style="text-align:right" | '''47.2''' |
||
|} |
|} |
||
</div> |
|||
* <sup>(a)</sup> Shareholders' equity excludes the other comprehensive income as well as the undated and deeply subordinated debt. |
* <sup>(a)</sup> Shareholders' equity excludes the other comprehensive income as well as the undated and deeply subordinated debt. |
||
* <sup>(b)</sup> Shareholders' equity excludes the undated and deeply subordinated debt. CSM is net of tax and Group Share. |
* <sup>(b)</sup> Shareholders' equity excludes the undated and deeply subordinated debt. CSM is net of tax and Group Share. |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Unrealized Gains and Losses on Invested Assets (Net of Tax) |
|+ Unrealized Gains and Losses on Invested Assets (Net of Tax) |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Government Bonds (recyclable) |
| style="text-align:left" | Government Bonds (recyclable) |
||
| Line 8,031: | Line 8,063: | ||
| style="text-align:right" | '''-10.9''' |
| style="text-align:right" | '''-10.9''' |
||
|} |
|} |
||
</div> |
|||
== 19. ROE&Gearing == |
== 19. ROE&Gearing == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Return on Equity (ROE) |
|+ Return on Equity (ROE) |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
! style="text-align:right" | Change in % points (FY25 vs FY24) |
! style="text-align:right; width:6em" | Change in % points (FY25 vs FY24) |
||
|- |
|- |
||
| style="text-align:left" | '''Net Income ROE''' |
| style="text-align:left" | '''Net Income ROE''' |
||
| Line 8,071: | Line 8,105: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
|||
* <sup>(a)</sup> Including adjustments to reflect net financial charges related to undated and deeply subordinated debt (recorded through shareholders' equity). |
* <sup>(a)</sup> Including adjustments to reflect net financial charges related to undated and deeply subordinated debt (recorded through shareholders' equity). |
||
| Line 8,076: | Line 8,111: | ||
* Financial interest treatment |
* Financial interest treatment |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Consolidated Financial Structure & Debt Gearing (in Euro billion) |
|+ Consolidated Financial Structure & Debt Gearing (in Euro billion) |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Financing Debt |
| style="text-align:left" | Financing Debt |
||
| Line 8,134: | Line 8,170: | ||
| style="text-align:right" | '''22.3%''' |
| style="text-align:right" | '''22.3%''' |
||
|} |
|} |
||
</div> |
|||
* <sup>(a)</sup> Shareholders' equity includes undated and deeply subordinated debts. |
* <sup>(a)</sup> Shareholders' equity includes undated and deeply subordinated debts. |
||
| Line 8,139: | Line 8,176: | ||
== 20. Information on Solvency II == |
== 20. Information on Solvency II == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Solvency II Rollforward |
|+ Solvency II Rollforward |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | Regulatory & model changes |
! style="text-align:right; width:6em" | Regulatory & model changes |
||
! style="text-align:right" | Normalized Capital Generation |
! style="text-align:right; width:6em" | Normalized Capital Generation |
||
! style="text-align:right" | Operating variance |
! style="text-align:right; width:6em" | Operating variance |
||
! style="text-align:right" | Economic variance (incl. FX) |
! style="text-align:right; width:6em" | Economic variance (incl. FX) |
||
! style="text-align:right" | Dividend & share buy-backs |
! style="text-align:right; width:6em" | Dividend & share buy-backs |
||
! style="text-align:right" | Debt |
! style="text-align:right; width:6em" | Debt |
||
! style="text-align:right" | M&A, In-force and Other |
! style="text-align:right; width:6em" | M&A, In-force and Other |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''Eligible Own Fund (EOF)''' |
| style="text-align:left" | '''Eligible Own Fund (EOF)''' |
||
| Line 8,185: | Line 8,223: | ||
| style="text-align:right" | '''224%''' |
| style="text-align:right" | '''224%''' |
||
|} |
|} |
||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ EOF Tiering |
|+ EOF Tiering |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | Total |
! style="text-align:right; width:6em" | Total |
||
! style="text-align:right" | Unrestricted Tier |
! style="text-align:right; width:6em" | Unrestricted Tier |
||
! style="text-align:right" | Restricted Tier |
! style="text-align:right; width:6em" | Restricted Tier |
||
! colspan="2" style="text-align:center" | Tier |
! colspan="2" style="text-align:center" | Tier |
||
|- |
|- |
||
| Line 8,264: | Line 8,304: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
|||
* |
* (*) Transitional measures on basic own funds applied on subordinated debts eligible under Solvency I regulation. These subordinated debts were also eligible under Solvency II until December 31, 2025. They are no longer eligible since January 1, 2026. |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Solvency II Key Sensitivities (in pts) |
|+ Solvency II Key Sensitivities (in pts) |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | FY24 |
! style="text-align:right; width:6em" | FY24 |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | Interest Rate +50 bps |
| style="text-align:left" | Interest Rate +50 bps |
||
| Line 8,313: | Line 8,355: | ||
| style="text-align:right" | -5 pts |
| style="text-align:right" | -5 pts |
||
|} |
|} |
||
</div> |
|||
== 21. IFRS17 SHE to Group EOF == |
== 21. IFRS17 SHE to Group EOF == |
||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" style="width:100%" |
{| class="wikitable" style="width:100%" |
||
|+ Reconciliation IFRS17/9 Shareholders' Equity to Solvency II Eligible Own Funds |
|+ Reconciliation IFRS17/9 Shareholders' Equity to Solvency II Eligible Own Funds |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:right" | FY25 |
! style="text-align:right; width:6em" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | '''IFRS SHAREHOLDERS' EQUITY''' |
| style="text-align:left" | '''IFRS SHAREHOLDERS' EQUITY''' |
||
| Line 8,375: | Line 8,419: | ||
| style="text-align:right" | '''56.4''' |
| style="text-align:right" | '''56.4''' |
||
|} |
|} |
||
</div> |
|||
Latest revision as of 18:21, 9 June 2026
AXA — Full Year 2025 Financial Supplement (auto-extracted from the published .xlsx).
1. Market Data
| — | 1H24 | FY24 | 1H25 | FY25 | Average 1H24 | Average FY24 | Average 1H25 | Average FY25 |
|---|---|---|---|---|---|---|---|---|
| USD | 1.07 | 1.04 | 1.17 | 1.17 | 1.08 | 1.08 | 1.09 | 1.13 |
| JPY | 172 | 163 | 170 | 184 | 165 | 164 | 162 | 169 |
| GBP | 0.85 | 0.83 | 0.86 | 0.87 | 0.85 | 0.85 | 0.84 | 0.86 |
| CHF | 0.96 | 0.94 | 0.93 | 0.93 | 0.96 | 0.95 | 0.94 | 0.94 |
| HKD | 8.37 | 8.04 | 9.21 | 9.14 | 8.45 | 8.44 | 8.53 | 8.82 |
| — | Average 1H24 | Average FY24 | Average 1H25 | Average FY25 |
|---|---|---|---|---|
| EUR | 2.79% | 2.84% | 2.57% | 2.59% |
| USD | 4.35% | 4.41% | 4.40% | 4.23% |
| JPY | 0.22% | 0.42% | 0.89% | 1.01% |
| GBP | 4.00% | 4.25% | 4.38% | 4.31% |
| CHF | 1.05% | 0.82% | 0.18% | 0.16% |
| HKD | 3.75% | 3.67% | 3.45% | 3.18% |
| — | Closing 1H24 | Closing FY24 | Closing 1H25 | Closing FY25 |
|---|---|---|---|---|
| EUR | 3.06% | 2.71% | 2.91% | 3.17% |
| USD | 4.54% | 4.66% | 4.43% | 4.45% |
| JPY | 1.04% | 1.07% | 1.44% | 2.08% |
| GBP | 4.27% | 4.48% | 4.56% | 4.55% |
| CHF | 0.98% | 0.38% | 0.53% | 0.67% |
| HKD | 3.79% | 3.91% | 3.02% | 3.21% |
2. UE by LOB and Net Income
| EUR million | Group | Property & Casualty | Life & Health | Asset Management* | Holdings | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 35,273 | 72,104 | 37,209 | 75,071 | 27,294 | 55,898 | 28,697 | 57,656 | 7,979 | 16,207 | 8,512 | 17,416 | — | — | — | — | — | — | — | — |
| Combined Ratio | — | — | — | — | 90.2% | 91.0% | 90.0% | 90.6% | 97.6% | 97.4% | 97.1% | 97.2% | — | — | — | — | — | — | — | — |
| Technical Margin | 2,877 | 5,421 | 3,107 | 5,888 | 2,682 | 5,006 | 2,859 | 5,409 | 195 | 415 | 248 | 479 | — | — | — | — | — | — | — | — |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | — | — | — | — | 1,395 | 2,775 | 1,428 | 2,954 | — | — | — | — | — | — | — | — |
| Technical Experience | -64 | -95 | -30 | -150 | — | — | — | — | -64 | -95 | -30 | -150 | — | — | — | — | — | — | — | — |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 2,064 | 3,971 | 2,148 | 4,013 | 1,324 | 2,559 | 1,343 | 2,631 | 536 | 975 | 563 | 946 | 24 | 35 | 14 | 14 | 181 | 402 | 228 | 422 |
| Other Revenues | 1,459 | 3,054 | 1,625 | 2,167 | — | — | — | — | — | — | — | — | 937 | 2,004 | 1,018 | 1,018 | 522 | 1,050 | 607 | 1,149 |
| Other Expenses | -1,624 | -3,479 | -1,868 | -2,900 | — | — | — | — | — | — | — | — | -698 | -1,493 | -793 | -793 | -925 | -1,986 | -1,075 | -2,107 |
| Debt Financing Charges | -471 | -948 | -452 | -928 | — | — | — | — | — | — | — | — | — | — | — | — | -471 | -948 | -452 | -928 |
| Underlying Earnings Before Tax | 5,638 | 10,700 | 5,958 | 11,044 | 4,006 | 7,565 | 4,202 | 8,040 | 2,061 | 4,070 | 2,209 | 4,229 | 263 | 546 | 239 | 239 | -693 | -1,482 | -692 | -1,464 |
| Tax | -1,427 | -2,662 | -1,503 | -2,644 | -1,046 | -1,952 | -1,074 | -2,060 | -412 | -874 | -462 | -800 | -69 | -160 | -68 | -68 | 100 | 324 | 101 | 284 |
| Income from Affiliates & Other | 122 | 218 | 111 | 168 | 2 | 3 | 1 | 3 | 103 | 186 | 101 | 157 | 16 | 29 | 8 | 8 | 0 | 0 | 0 | 0 |
| Minority Interests | -89 | -179 | -101 | -199 | -56 | -106 | -63 | -111 | -27 | -60 | -34 | -85 | -6 | -13 | -4 | -4 | 0 | 0 | 0 | 0 |
| Underlying Earnings Group Share | 4,244 | 8,078 | 4,465 | 8,368 | 2,908 | 5,510 | 3,067 | 5,872 | 1,725 | 3,323 | 1,814 | 3,501 | 204 | 402 | 175 | 175 | -592 | -1,157 | -591 | -1,180 |
| Underlying Earnings Growth Rate (constant FX) | 4% | 7% | 6% | 6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying ROE | 16.6% | 15.2% | 17.5% | 16.0% | — | 16.2% | — | 17.3% | — | 13.6% | — | 14.4% | — | 26.0% | — | n.a. | — | — | — | — |
| Net Realized Capital Gains & Losses | 93 | 195 | 66 | 138 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Change in Fair Value of Assets & Derivatives | -43 | 83 | -467 | -813 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Amortization of customer intangibles | -50 | -131 | -48 | -86 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Integration and Restructuring Costs | -78 | -240 | -63 | -197 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Exceptional Items | -147 | -99 | -30 | 2,386 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income Group Share | 4,020 | 7,886 | 3,922 | 9,797 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deeply Subordinated and Undated Subordinated Debt Charges | -106 | -201 | -86 | -174 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings for EPS calculation | 4,138 | 7,877 | 4,379 | 8,195 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income for EPS calculation | 3,914 | 7,685 | 3,836 | 9,623 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
- (*) AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.
- (**) Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.
3. UE by Geography
| EUR million | Group | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM* | Transversal & Other | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 35,273 | 72,104 | 37,209 | 75,071 | 9,046 | 18,698 | 9,567 | 19,555 | 11,839 | 24,005 | 12,661 | 25,724 | 9,022 | 18,530 | 9,428 | 18,699 | 4,312 | 8,750 | 4,478 | 8,986 | — | — | — | — | 1,053 | 2,122 | 1,075 | 2,107 |
| Combined Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Technical Margin | 2,877 | 5,421 | 3,107 | 5,888 | 692 | 1,470 | 658 | 1,485 | 998 | 1,957 | 1,176 | 2,357 | 1,111 | 1,820 | 1,074 | 1,928 | 70 | 81 | 150 | 9 | — | — | — | — | 6 | 93 | 49 | 109 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 407 | 823 | 419 | 895 | 468 | 920 | 471 | 984 | 4 | 3 | 0 | 1 | 516 | 1,029 | 538 | 1,074 | — | — | — | — | 0 | 0 | 0 | 0 |
| Technical Experience | -64 | -95 | -30 | -150 | -40 | -96 | -37 | -81 | -11 | -8 | 8 | -70 | 3 | 2 | 0 | -5 | -17 | 7 | -1 | 6 | — | — | — | — | 0 | 0 | 0 | 0 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 2,064 | 3,971 | 2,148 | 4,013 | 350 | 613 | 380 | 667 | 784 | 1,486 | 765 | 1,398 | 283 | 616 | 308 | 651 | 382 | 741 | 425 | 782 | 24 | 35 | 14 | 14 | 241 | 480 | 255 | 502 |
| Other Revenues | 1,459 | 3,054 | 1,625 | 2,167 | 53 | 108 | 44 | 91 | -18 | -32 | -8 | -12 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | -3 | 937 | 2,004 | 1,018 | 1,018 | 488 | 974 | 573 | 1,073 |
| Other Expenses | -1,624 | -3,479 | -1,868 | -2,900 | -83 | -180 | -79 | -168 | -10 | -25 | -6 | -3 | 0 | 0 | 0 | 0 | -9 | -20 | -14 | -26 | -698 | -1,493 | -793 | -793 | -823 | -1,761 | -976 | -1,910 |
| Debt Financing Charges | -471 | -948 | -452 | -928 | 0 | 0 | 0 | 0 | -1 | -2 | -1 | -2 | -16 | -33 | -16 | -32 | -7 | -12 | -4 | -6 | — | — | — | — | -447 | -902 | -431 | -887 |
| Underlying Earnings Before Tax | 5,638 | 10,700 | 5,958 | 11,044 | 1,380 | 2,738 | 1,384 | 2,888 | 2,210 | 4,297 | 2,406 | 4,651 | 1,385 | 2,409 | 1,366 | 2,543 | 935 | 1,826 | 1,093 | 1,835 | 263 | 546 | 239 | 239 | -535 | -1,116 | -530 | -1,113 |
| Tax | -1,427 | -2,662 | -1,503 | -2,644 | -350 | -676 | -308 | -665 | -536 | -1,004 | -568 | -1,039 | -355 | -588 | -342 | -650 | -205 | -443 | -294 | -434 | -69 | -160 | -68 | -68 | 88 | 209 | 76 | 212 |
| Income from Affiliates & Other | 122 | 218 | 111 | 168 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102 | 181 | 103 | 160 | 16 | 29 | 8 | 8 | 0 | 0 | 0 | 0 |
| Minority Interests | -89 | -179 | -101 | -199 | 0 | 0 | 0 | 0 | -48 | -105 | -56 | -126 | 0 | 0 | 0 | 0 | -34 | -60 | -39 | -68 | -6 | -13 | -4 | -4 | 0 | 0 | -1 | -2 |
| Underlying Earnings Group share | 4,244 | 8,078 | 4,465 | 8,368 | 1,034 | 2,071 | 1,076 | 2,224 | 1,626 | 3,187 | 1,782 | 3,486 | 1,030 | 1,820 | 1,024 | 1,893 | 798 | 1,504 | 862 | 1,493 | 204 | 402 | 175 | 175 | -447 | -907 | -455 | -903 |
- (*) AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.
- (**) Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.
| Outstanding Shares Excluding Treasury Shares (a) | Weighted Average Number | |||
|---|---|---|---|---|
| — | FY24 | FY25 | FY24 | FY25 |
| Basic Number of Shares | — | — | — | — |
| As of Beginning of Period | 2,226.2 | 2,175.4 | 2,226.2 | 2,175.4 |
| Increase of Capital Dedicated to Employees | 12.9 | 12.7 | 0.9 | 1.0 |
| Exercice of Stock-options | 2.6 | 1.1 | 1.4 | 0.6 |
| Other Movement of Treasury Shares | 4.6 | 4.2 | 17.5 | 6.3 |
| Capital Increase / (Decrease) | -70.9 | -138.0 | -55.2 | -64.9 |
| As at End of Period | 2,175.4 | 2,055.4 | — | — |
| During the Period | — | — | 2,190.8 | 2,118.3 |
| Fully Diluted Number of Shares | — | — | — | — |
| Stock Options | — | — | 0.8 | 0.6 |
| Performance Shares | — | — | 5.6 | 5.1 |
| During the Period (A) | — | — | 2,197.1 | 2,124.0 |
| Earnings Group Share: | — | — | — | — |
| Net Income | — | — | 7,886 | 9,797 |
| Underlying Earnings | — | — | 8,078 | 8,368 |
| Impact of undated and deeply subordinated debts: | — | — | — | — |
| Undated and deeply subordinated debt charges | — | — | -201 | -174 |
| Earnings for EPS Calculation: | — | — | — | — |
| Net Income for EPS Calculation (B) | — | — | 7,685 | 9,623 |
| Underlying Earnings for EPS Calculation (C) | — | — | 7,877 | 8,195 |
| Fully Diluted Euro per Share (EPS) | — | — | — | — |
| EPS (B/A) | — | — | 3.50 | 4.53 |
| Underlying EPS (C/A) | — | — | 3.59 | 3.86 |
- (a) Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24.
5. P&C UE by Sub LOB
| EUR million | Total | Commercial lines | Personal lines | AXA XL Reinsurance | Intercompany eliminations | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 27,294 | 55,898 | 28,697 | 57,656 | 18,657 | 38,019 | 19,575 | 39,090 | 9,144 | 18,705 | 9,513 | 19,276 | 1,155 | 2,394 | 1,299 | 2,493 | -1,662 | -3,220 | -1,689 | -3,203 |
| Current Accident Year Loss Ratio | 67.0% | 67.7% | 66.7% | 66.9% | 68.1% | 68.8% | 68.0% | 68.0% | 69.8% | 70.0% | 68.8% | 69.1% | 69.7% | 70.6% | 70.8% | 71.9% | — | — | — | — |
| Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) | 67.4% | 67.4% | 67.0% | 67.0% | 69.2% | 69.4% | 69.3% | 68.8% | 68.8% | 68.5% | 67.5% | 67.9% | 68.0% | 67.9% | 69.4% | 71.5% | — | — | — | — |
| Undiscounted Current Accident Year Nat Cats | 3.6% | 3.8% | 3.5% | 3.4% | 2.7% | 2.9% | 2.7% | 2.6% | 4.0% | 4.1% | 3.8% | 3.6% | 10.6% | 10.4% | 9.2% | 8.7% | — | — | — | — |
| Current Accident Year Discounting | -3.9% | -3.6% | -3.9% | -3.5% | -3.7% | -3.5% | -3.9% | -3.5% | -3.0% | -2.6% | -2.6% | -2.4% | -8.8% | -7.7% | -7.8% | -8.3% | — | — | — | — |
| Prior Year Reserve Development Ratio | -1.5% | -1.6% | -1.1% | -1.1% | -1.1% | -1.2% | -1.3% | -0.8% | -2.3% | -1.8% | -0.6% | -1.6% | -1.1% | -0.8% | -0.3% | 0.0% | — | — | — | — |
| Expense Ratio | 24.7% | 25.0% | 24.5% | 24.8% | 23.1% | 23.6% | 23.2% | 23.5% | 25.5% | 25.7% | 25.1% | 25.2% | 10.0% | 9.9% | 9.1% | 9.4% | — | — | — | — |
| Combined Ratio | 90.2% | 91.0% | 90.0% | 90.6% | 90.1% | 91.1% | 89.9% | 90.7% | 92.9% | 93.9% | 93.3% | 92.8% | 78.7% | 79.7% | 79.6% | 81.4% | — | — | — | — |
| Technical Margin | 2,682 | 5,006 | 2,859 | 5,409 | 1,850 | 3,372 | 1,968 | 3,616 | 645 | 1,136 | 638 | 1,392 | 246 | 486 | 265 | 464 | -60 | 12 | -12 | -63 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Technical Experience | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 1,324 | 2,559 | 1,343 | 2,631 | 993 | 1,831 | 1,004 | 1,941 | 240 | 538 | 275 | 523 | 119 | 210 | 85 | 186 | -28 | -20 | -20 | -20 |
| Investment Income | 1,967 | 3,731 | 2,088 | 3,988 | 1,427 | 2,625 | 1,512 | 2,864 | 366 | 761 | 422 | 794 | 202 | 365 | 174 | 350 | -28 | -20 | -20 | -20 |
| Insurance Finance Expenses | -643 | -1,172 | -745 | -1,358 | -434 | -794 | -508 | -922 | -126 | -223 | -148 | -272 | -83 | -155 | -90 | -163 | 0 | 0 | 0 | 0 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 4,006 | 7,565 | 4,202 | 8,040 | 2,843 | 5,203 | 2,973 | 5,557 | 886 | 1,674 | 913 | 1,914 | 365 | 696 | 349 | 650 | -87 | -8 | -33 | -82 |
| Tax | -1,046 | -1,952 | -1,074 | -2,060 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Income from Affiliates & Other | 2 | 3 | 1 | 3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Minority Interests | -56 | -106 | -63 | -111 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Group share | 2,908 | 5,510 | 3,067 | 5,872 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Closing Invested Assets | 113,515 | 118,104 | 116,895 | 117,507 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| o/w VFA | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| o/w Non VFA | 113,515 | 118,104 | 116,895 | 117,507 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 19,284 | 16,006 | 19,766 | 16,040 | 12,070 | 9,480 | 12,240 | 9,127 | 6,369 | 5,478 | 6,831 | 5,871 | 1,572 | 1,075 | 1,436 | 1,009 | -728 | -27 | -740 | 32 |
| Best Estimate for incurred Claims net of reinsurance | 69,800 | 71,751 | 70,215 | 70,567 | 45,710 | 46,570 | 46,591 | 47,002 | 17,809 | 18,308 | 17,781 | 17,402 | 6,704 | 6,830 | 6,290 | 6,198 | -423 | 43 | -447 | -35 |
- For long-term business
- Best Estimate Liabilities net of reinsurance
6. P&C UE by Geography
| EUR million | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | Transversal & Other | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | o/w AXA XL Insurance | FY24 | o/w AXA XL Insurance | 1H25 | o/w AXA XL Insurance | FY25 | o/w AXA XL Insurance | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 27,294 | 55,898 | 28,697 | 57,656 | 4,393 | 9,194 | 4,697 | 9,768 | 10,060 | 20,400 | 10,610 | 21,305 | 9,022 | 7,867 | 18,530 | 16,136 | 9,428 | 8,129 | 18,699 | 16,207 | 2,855 | 5,825 | 2,975 | 5,949 | 963 | 1,948 | 987 | 1,935 |
| Current Accident Year Loss Ratio | 67.0% | 67.7% | 66.7% | 66.9% | 69.4% | 68.9% | 70.6% | 70.1% | 66.5% | 66.9% | 64.7% | 65.1% | 67.5% | 67.2% | 69.2% | 69.0% | 68.4% | 68.0% | 68.8% | 68.3% | 68.6% | 69.3% | 68.2% | 69.6% | 53.2% | 51.0% | 48.0% | 44.6% |
| Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) | 67.4% | 67.4% | 67.0% | 67.0% | 71.3% | 69.7% | 70.6% | 70.2% | 65.0% | 65.5% | 64.1% | 64.3% | 68.8% | 68.9% | 69.3% | 69.5% | 69.7% | 69.8% | 69.8% | 69.6% | 70.0% | 70.4% | 69.7% | 70.2% | 52.9% | 51.1% | 48.0% | 44.5% |
| Undiscounted Current Accident Year Nat Cats | 3.6% | 3.8% | 3.5% | 3.4% | 3.4% | 3.8% | 4.8% | 4.5% | 4.5% | 4.1% | 3.3% | 3.1% | 3.8% | 2.8% | 4.6% | 3.8% | 4.2% | 3.4% | 3.9% | 3.1% | 0.8% | 0.9% | 0.8% | 1.6% | 1.4% | 1.1% | 1.3% | 1.2% |
| Current Accident Year Discounting | -3.9% | -3.6% | -3.9% | -3.5% | -5.3% | -4.6% | -4.8% | -4.6% | -3.1% | -2.8% | -2.7% | -2.3% | -5.1% | -4.6% | -4.7% | -4.2% | -5.5% | -5.2% | -4.9% | -4.4% | -2.2% | -2.0% | -2.3% | -2.2% | -1.1% | -1.2% | -1.2% | -1.1% |
| Prior Year Reserve Development Ratio | -1.5% | -1.6% | -1.1% | -1.1% | -3.5% | -3.9% | -2.6% | -2.9% | -2.1% | -2.1% | -1.1% | -1.3% | -0.1% | 0.0% | -0.1% | 0.0% | -0.2% | -0.2% | 0.0% | 0.0% | -0.1% | 0.1% | -1.0% | -0.2% | -3.7% | -5.7% | -4.0% | -1.9% |
| Expense Ratio | 24.7% | 25.0% | 24.5% | 24.8% | 21.9% | 21.9% | 20.7% | 20.4% | 25.9% | 26.2% | 26.0% | 26.2% | 20.3% | 21.8% | 21.0% | 22.7% | 20.4% | 22.2% | 20.9% | 22.6% | 29.4% | 29.6% | 29.0% | 29.8% | 50.5% | 50.9% | 52.5% | 52.8% |
| Combined Ratio | 90.2% | 91.0% | 90.0% | 90.6% | 87.8% | 86.8% | 88.6% | 87.5% | 90.3% | 91.0% | 89.6% | 90.0% | 87.7% | 89.0% | 90.2% | 91.7% | 88.6% | 90.0% | 89.7% | 91.0% | 98.0% | 99.1% | 96.2% | 99.2% | 100.1% | 96.2% | 96.5% | 95.5% |
| Technical Margin | 2,682 | 5,006 | 2,859 | 5,409 | 538 | 1,212 | 533 | 1,220 | 977 | 1,844 | 1,104 | 2,127 | 1,111 | 865 | 1,820 | 1,335 | 1,074 | 809 | 1,928 | 1,464 | 57 | 55 | 114 | 48 | -1 | 74 | 35 | 86 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Technical Experience | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 1,324 | 2,559 | 1,343 | 2,631 | 251 | 421 | 261 | 468 | 473 | 912 | 461 | 876 | 273 | 159 | 596 | 387 | 298 | 213 | 632 | 445 | 242 | 484 | 261 | 530 | 86 | 146 | 62 | 125 |
| Investment Income | 1,967 | 3,731 | 2,088 | 3,988 | 334 | 572 | 373 | 675 | 658 | 1,244 | 667 | 1,257 | 614 | 416 | 1,233 | 868 | 681 | 507 | 1,331 | 981 | 261 | 518 | 292 | 585 | 100 | 164 | 74 | 140 |
| Insurance Finance Expenses | -643 | -1,172 | -745 | -1,358 | -83 | -151 | -112 | -207 | -185 | -332 | -206 | -381 | -341 | -257 | -637 | -481 | -384 | -294 | -699 | -536 | -20 | -35 | -31 | -55 | -14 | -18 | -12 | -15 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 4,006 | 7,565 | 4,202 | 8,040 | 788 | 1,633 | 794 | 1,688 | 1,450 | 2,757 | 1,564 | 3,002 | 1,384 | 1,024 | 2,417 | 1,721 | 1,372 | 1,022 | 2,560 | 1,910 | 299 | 539 | 375 | 579 | 85 | 220 | 97 | 211 |
| Tax | -1,046 | -1,952 | -1,074 | -2,060 | -249 | -472 | -220 | -451 | -352 | -671 | -384 | -734 | -352 | -257 | -588 | -457 | -339 | -252 | -647 | -482 | -77 | -159 | -110 | -170 | -15 | -62 | -21 | -58 |
| Income from Affiliates & Other | 2 | 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 1 | 3 | 0 | 0 | 0 | 0 |
| Minority Interests | -56 | -106 | -63 | -111 | 0 | 0 | 0 | 0 | -25 | -57 | -28 | -52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30 | -49 | -34 | -57 | 0 | 0 | -1 | -2 |
| Underlying Earnings Group share | 2,908 | 5,510 | 3,067 | 5,872 | 539 | 1,161 | 574 | 1,237 | 1,073 | 2,029 | 1,152 | 2,216 | 1,032 | 767 | 1,828 | 1,264 | 1,032 | 770 | 1,913 | 1,427 | 194 | 334 | 233 | 355 | 70 | 158 | 75 | 151 |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 19,284 | 16,006 | 19,766 | 16,040 | 2,153 | 1,712 | 2,221 | 1,783 | 7,151 | 5,166 | 7,591 | 5,534 | 7,478 | 5,905 | 7,028 | 5,948 | 7,315 | 5,879 | 6,467 | 5,461 | 1,802 | 1,834 | 1,935 | 2,024 | 700 | 266 | 705 | 231 |
| Best Estimate for incurred Claims net of reinsurance | 69,800 | 71,751 | 70,215 | 70,567 | 13,485 | 13,889 | 13,900 | 13,882 | 24,834 | 25,955 | 26,003 | 25,737 | 24,865 | 18,223 | 25,915 | 19,146 | 24,533 | 18,295 | 25,044 | 18,897 | 3,385 | 3,640 | 3,510 | 3,804 | 3,231 | 2,351 | 2,269 | 2,101 |
- For long-term business
- Best Estimate Liabilities net of reinsurance
7. L&H UE by LOB
| EUR million | Total | Life | Health | Employee Benefits* (out of Total Life & Health) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 7,979 | 16,207 | 8,512 | 17,416 | 2,112 | 4,247 | 2,211 | 4,444 | 5,867 | 11,960 | 6,301 | 12,972 | 5,592 | 11,482 | 5,931 | 12,035 |
| Combined Ratio | 97.6% | 97.4% | 97.1% | 97.2% | 94.5% | 95.5% | 95.2% | 95.4% | 98.6% | 98.1% | 97.8% | 97.9% | 98.2% | 97.8% | 97.4% | 97.1% |
| Technical Margin | 195 | 415 | 248 | 479 | 116 | 191 | 107 | 206 | 79 | 224 | 141 | 273 | 101 | 248 | 156 | 347 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 1,136 | 2,253 | 1,158 | 2,415 | 259 | 522 | 270 | 539 | 58 | 110 | 59 | 107 |
| Technical Experience | -64 | -95 | -30 | -150 | -71 | -98 | -28 | -139 | 7 | 3 | -2 | -11 | 17 | 37 | 22 | 38 |
| Actual vs. Expected Cash Flows | 9 | -15 | 12 | 39 | -4 | -33 | 10 | 37 | 13 | 18 | 2 | 2 | -3 | -2 | -5 | -8 |
| Risk Adjustment Release | 30 | 59 | 44 | 72 | 25 | 51 | 37 | 59 | 4 | 8 | 7 | 13 | 2 | 4 | 7 | 8 |
| Changes in Onerous Contracts | -32 | 6 | -12 | -29 | -30 | 9 | -10 | -25 | -1 | -2 | -2 | -4 | 0 | 0 | 0 | 0 |
| Other Long-term | -72 | -145 | -74 | -232 | -63 | -124 | -65 | -211 | -8 | -21 | -9 | -22 | 19 | 35 | 20 | 38 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 536 | 975 | 563 | 946 | 454 | 799 | 462 | 738 | 82 | 176 | 101 | 209 | 75 | 157 | 91 | 175 |
| Investment Income | 1,319 | 2,525 | 1,329 | 2,484 | 1,159 | 2,209 | 1,159 | 2,142 | 160 | 317 | 170 | 341 | 219 | 429 | 232 | 456 |
| Insurance Finance Expenses | -783 | -1,551 | -767 | -1,538 | -705 | -1,410 | -697 | -1,405 | -78 | -140 | -69 | -133 | -144 | -272 | -141 | -281 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 2,061 | 4,070 | 2,209 | 4,229 | 1,634 | 3,145 | 1,699 | 3,219 | 427 | 925 | 510 | 1,010 | 252 | 552 | 328 | 666 |
| Tax | -412 | -874 | -462 | -800 | -316 | -635 | -329 | -584 | -96 | -239 | -133 | -216 | -46 | -111 | -64 | -110 |
| Income from Affiliates & Other | 103 | 186 | 101 | 157 | 101 | 182 | 93 | 154 | 2 | 4 | 8 | 2 | — | — | — | — |
| Minority Interests | -27 | -60 | -34 | -85 | -27 | -56 | -30 | -75 | 0 | -4 | -3 | -9 | — | — | — | — |
| Underlying Earnings Group share | 1,725 | 3,323 | 1,814 | 3,501 | 1,392 | 2,636 | 1,433 | 2,715 | 333 | 687 | 381 | 787 | 205 | 441 | 264 | 556 |
| Closing Invested Assets | 329,460 | 345,008 | 338,447 | 334,840 | — | — | — | — | — | — | — | — | — | — | — | — |
| o/w VFA | 234,783 | 230,205 | 229,844 | 226,937 | — | — | — | — | — | — | — | — | — | — | — | — |
| o/w Non VFA | 94,677 | 114,803 | 108,603 | 107,903 | — | — | — | — | — | — | — | — | — | — | — | — |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 2,446 | 2,096 | 2,856 | 2,511 | 157 | 96 | 105 | 21 | 2,289 | 2,000 | 2,750 | 2,490 | — | — | — | — |
| Best Estimate for incurred Claims net of reinsurance | 13,876 | 14,162 | 13,960 | 14,592 | 11,589 | 11,778 | 11,623 | 11,205 | 2,286 | 2,384 | 2,337 | 3,386 | — | — | — | — |
| For long-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Best Estimate Liabilities net of reinsurance | 295,342 | 306,249 | 301,040 | 300,391 | 275,276 | 285,391 | 280,314 | 280,280 | 20,066 | 20,858 | 20,726 | 20,112 | — | — | — | — |
| o/w VFA Gross of reinsurance | 264,013 | 273,094 | 266,960 | 271,902 | 243,037 | 251,273 | 244,964 | 250,326 | 20,977 | 21,821 | 21,996 | 21,576 | — | — | — | — |
| o/w BBA Gross of reinsurance | 50,097 | 51,845 | 51,524 | 45,307 | 50,917 | 52,713 | 52,731 | 46,724 | -821 | -868 | -1,207 | -1,417 | — | — | — | — |
| o/w Reinsurance | -18,768 | -18,690 | -17,443 | -16,817 | -18,679 | -18,595 | -17,381 | -16,770 | -90 | -95 | -62 | -47 | — | — | — | — |
- (*) Employee Benefits include Group Protection and Group Health contracts.
8. L&H UE by Geography
| EUR million | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | Transversal & Other | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 7,979 | 16,207 | 8,512 | 17,416 | 4,654 | 9,503 | 4,870 | 9,787 | 1,778 | 3,604 | 2,051 | 4,419 | 0 | 0 | 0 | 0 | 1,457 | 2,925 | 1,503 | 3,037 | 90 | 174 | 88 | 172 |
| Combined Ratio | 97.6% | 97.4% | 97.1% | 97.2% | 96.7% | 97.3% | 97.4% | 97.3% | 98.8% | 96.9% | 96.4% | 94.8% | 0.0% | 0.0% | 0.0% | 0.0% | 99.1% | 99.1% | 97.6% | 101.3% | 92.2% | 89.1% | 83.6% | 86.7% |
| Technical Margin | 195 | 415 | 248 | 479 | 155 | 258 | 124 | 265 | 21 | 113 | 73 | 230 | 0 | 0 | 0 | 0 | 13 | 26 | 36 | -39 | 7 | 19 | 14 | 23 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 407 | 823 | 419 | 895 | 468 | 920 | 471 | 984 | 4 | 3 | 0 | 1 | 516 | 1,029 | 538 | 1,074 | 0 | 0 | 0 | 0 |
| Technical Experience | -64 | -95 | -30 | -150 | -40 | -96 | -37 | -81 | -11 | -8 | 8 | -70 | 3 | 2 | 0 | -5 | -17 | 7 | -1 | 6 | 0 | 0 | 0 | 0 |
| Actual vs. Expected Cash Flows | 9 | -15 | 12 | 39 | 8 | -8 | 2 | 15 | 5 | -11 | -11 | -6 | -2 | -3 | -1 | -6 | 0 | 8 | 22 | 35 | 0 | 0 | 0 | 0 |
| Risk Adjustment Release | 30 | 59 | 44 | 72 | 5 | 15 | 9 | 14 | 11 | 21 | 21 | 32 | 0 | 1 | 0 | 1 | 13 | 23 | 13 | 25 | 0 | 0 | 0 | 0 |
| Changes in Onerous Contracts | -32 | 6 | -12 | -29 | 0 | 0 | 0 | 0 | -33 | -25 | -13 | -36 | 5 | 5 | 0 | 0 | -3 | 26 | 1 | 7 | 0 | 0 | 0 | 0 |
| Other Long-term | -72 | -145 | -74 | -232 | -52 | -103 | -49 | -111 | 7 | 7 | 12 | -61 | 0 | 0 | 0 | 0 | -26 | -50 | -37 | -61 | 0 | 0 | 0 | 0 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 536 | 975 | 563 | 946 | 100 | 192 | 118 | 197 | 284 | 504 | 269 | 477 | 10 | 19 | 10 | 20 | 142 | 260 | 165 | 250 | 0 | 0 | 0 | 2 |
| Investment Income | 1,319 | 2,525 | 1,329 | 2,484 | 370 | 701 | 370 | 703 | 490 | 916 | 478 | 889 | 13 | 27 | 14 | 27 | 446 | 882 | 467 | 862 | 0 | 0 | 0 | 2 |
| Insurance Finance Expenses | -783 | -1,551 | -767 | -1,538 | -270 | -509 | -252 | -507 | -206 | -412 | -209 | -411 | -3 | -7 | -4 | -8 | -303 | -622 | -301 | -612 | 0 | 0 | 0 | 0 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 2,061 | 4,070 | 2,209 | 4,229 | 622 | 1,176 | 624 | 1,276 | 762 | 1,529 | 821 | 1,622 | 17 | 25 | 10 | 16 | 654 | 1,322 | 739 | 1,291 | 7 | 19 | 14 | 25 |
| Tax | -412 | -874 | -462 | -800 | -106 | -220 | -100 | -237 | -180 | -376 | -176 | -285 | -3 | 0 | -2 | -4 | -123 | -277 | -182 | -272 | 0 | 0 | -1 | -4 |
| Income from Affiliates & Other | 103 | 186 | 101 | 157 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 177 | 101 | 157 | 0 | 0 | 0 | 0 |
| Minority Interests | -27 | -60 | -34 | -85 | 0 | 0 | 0 | 0 | -23 | -49 | -28 | -74 | 0 | 0 | 0 | 0 | -4 | -12 | -5 | -11 | 0 | 0 | 0 | 0 |
| Underlying Earnings Group share | 1,725 | 3,323 | 1,814 | 3,501 | 519 | 964 | 524 | 1,039 | 559 | 1,104 | 616 | 1,264 | 14 | 25 | 8 | 12 | 627 | 1,211 | 653 | 1,165 | 7 | 19 | 14 | 22 |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 2,446 | 2,096 | 2,856 | 2,511 | 50 | -2 | 28 | -6 | 1,228 | 967 | 1,619 | 1,352 | 0 | 0 | 0 | 0 | 1,159 | 1,124 | 1,204 | 1,155 | 9 | 6 | 5 | 10 |
| Best Estimate for incurred Claims net of reinsurance | 13,876 | 14,162 | 13,960 | 14,592 | 12,589 | 12,831 | 12,443 | 12,850 | 773 | 871 | 1,015 | 1,186 | 0 | 0 | 0 | 0 | 501 | 447 | 487 | 541 | 13 | 14 | 15 | 15 |
| For long-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Best Estimate Liabilities net of reinsurance | 295,342 | 306,249 | 301,040 | 300,391 | 112,949 | 115,280 | 114,525 | 114,424 | 135,034 | 139,257 | 137,584 | 136,725 | 324 | 345 | 310 | 309 | 47,035 | 51,368 | 48,620 | 48,934 | 0 | 0 | 0 | 0 |
| o/w VFA Gross of reinsurance | 264,013 | 273,094 | 266,960 | 271,902 | 116,132 | 117,942 | 116,770 | 117,266 | 121,623 | 125,513 | 121,135 | 122,782 | 0 | 0 | 0 | 0 | 26,258 | 29,639 | 29,055 | 31,854 | 0 | 0 | 0 | 0 |
| o/w BBA Gross of reinsurance | 50,097 | 51,845 | 51,524 | 45,307 | 9,606 | 10,019 | 9,848 | 8,873 | 13,520 | 13,810 | 16,410 | 13,760 | 1,670 | 1,659 | 1,522 | 1,473 | 25,301 | 26,356 | 23,743 | 21,201 | 0 | 0 | 0 | 0 |
| o/w Reinsurance | -18,768 | -18,690 | -17,443 | -16,817 | -12,790 | -12,682 | -12,093 | -11,715 | -108 | -66 | 39 | 183 | -1,346 | -1,315 | -1,212 | -1,164 | -4,524 | -4,627 | -4,178 | -4,121 | 0 | 0 | 0 | 0 |
9. Life UE by Geography
| EUR million | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | Transversal & Other | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 2,112 | 4,247 | 2,211 | 4,444 | 1,902 | 3,843 | 2,005 | 4,044 | 53 | 109 | 54 | 106 | 0 | 0 | 0 | 0 | 157 | 296 | 152 | 295 | 0 | 0 | 0 | 0 |
| Combined Ratio | 94.5% | 95.5% | 95.2% | 95.4% | 95.1% | 96.3% | 95.9% | 96.1% | 79.8% | 77.0% | 79.0% | 77.3% | 0.0% | 0.0% | 0.0% | 0.0% | 92.3% | 91.5% | 91.5% | 91.6% | 0.0% | 0.0% | 0.0% | 0.0% |
| Technical Margin | 116 | 191 | 107 | 206 | 93 | 141 | 83 | 158 | 11 | 25 | 11 | 24 | 0 | 0 | 0 | 0 | 12 | 25 | 13 | 25 | 0 | 0 | 0 | 0 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,136 | 2,253 | 1,158 | 2,415 | 407 | 823 | 419 | 895 | 390 | 759 | 386 | 804 | 4 | 3 | 0 | 1 | 336 | 669 | 353 | 715 | 0 | 0 | 0 | 0 |
| Technical Experience | -71 | -98 | -28 | -139 | -40 | -96 | -37 | -81 | -4 | 12 | 13 | -53 | 3 | 2 | 0 | -5 | -30 | -16 | -4 | 0 | 0 | 0 | 0 | 0 |
| Actual vs. Expected Cash Flows | -4 | -33 | 10 | 37 | 8 | -8 | 2 | 15 | 3 | -11 | -11 | -6 | -2 | -3 | -1 | -6 | -12 | -10 | 20 | 33 | 0 | 0 | 0 | 0 |
| Risk Adjustment Release | 25 | 51 | 37 | 59 | 5 | 15 | 9 | 14 | 12 | 23 | 20 | 30 | 0 | 1 | 0 | 1 | 8 | 13 | 8 | 14 | 0 | 0 | 0 | 0 |
| Changes in Onerous Contracts | -30 | 9 | -10 | -25 | 0 | 0 | 0 | 0 | -32 | -23 | -13 | -33 | 5 | 5 | 0 | 0 | -3 | 26 | 3 | 8 | 0 | 0 | 0 | 0 |
| Other Long-term | -63 | -124 | -65 | -211 | -52 | -103 | -49 | -111 | 13 | 23 | 17 | -44 | 0 | 0 | 0 | 0 | -23 | -45 | -34 | -55 | 0 | 0 | 0 | 0 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 454 | 799 | 462 | 738 | 103 | 193 | 114 | 185 | 249 | 432 | 232 | 401 | 10 | 19 | 10 | 20 | 92 | 155 | 105 | 132 | 0 | 0 | 0 | 0 |
| Investment Income | 1,159 | 2,209 | 1,159 | 2,142 | 344 | 660 | 346 | 649 | 451 | 838 | 438 | 809 | 13 | 27 | 14 | 27 | 350 | 684 | 361 | 657 | 0 | 0 | 0 | 0 |
| Insurance Finance Expenses | -705 | -1,410 | -697 | -1,405 | -241 | -467 | -232 | -464 | -202 | -407 | -206 | -408 | -3 | -7 | -4 | -8 | -259 | -530 | -256 | -525 | 0 | 0 | 0 | 0 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 1,634 | 3,145 | 1,699 | 3,219 | 563 | 1,060 | 579 | 1,156 | 645 | 1,227 | 643 | 1,176 | 17 | 25 | 10 | 16 | 409 | 833 | 468 | 872 | 0 | 0 | 0 | 0 |
| Tax | -316 | -635 | -329 | -584 | -96 | -194 | -93 | -213 | -148 | -289 | -131 | -183 | -3 | 0 | -2 | -4 | -68 | -152 | -103 | -184 | 0 | 0 | 0 | 0 |
| Income from Affiliates & Other | 101 | 182 | 93 | 154 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97 | 173 | 93 | 154 | 0 | 0 | 0 | 0 |
| Minority Interests | -27 | -56 | -30 | -75 | 0 | 0 | 0 | 0 | -23 | -47 | -28 | -70 | 0 | 0 | 0 | 0 | -4 | -9 | -3 | -5 | 0 | 0 | 0 | 0 |
| Underlying Earnings Group share | 1,392 | 2,636 | 1,433 | 2,715 | 470 | 875 | 486 | 943 | 474 | 891 | 484 | 923 | 14 | 25 | 8 | 12 | 434 | 845 | 456 | 837 | 0 | 0 | 0 | 0 |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 157 | 96 | 105 | 21 | 23 | -19 | 4 | -41 | -3 | -14 | -35 | -24 | 0 | 0 | 0 | 0 | 137 | 129 | 137 | 86 | 0 | 0 | 0 | 0 |
| Best Estimate for incurred Claims net of reinsurance | 11,589 | 11,778 | 11,623 | 11,205 | 11,349 | 11,502 | 11,352 | 10,939 | 75 | 120 | 118 | 124 | 0 | 0 | 0 | 0 | 165 | 157 | 154 | 142 | 0 | 0 | 0 | 0 |
| For long-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Best Estimate Liabilities net of reinsurance | 275,276 | 285,391 | 280,314 | 280,280 | 112,949 | 115,280 | 114,525 | 114,424 | 114,389 | 117,841 | 116,058 | 115,433 | 324 | 345 | 310 | 309 | 47,614 | 51,926 | 49,420 | 50,113 | 0 | 0 | 0 | 0 |
| o/w VFA Gross of reinsurance | 243,037 | 251,273 | 244,964 | 250,326 | 116,132 | 117,942 | 116,770 | 117,266 | 100,727 | 103,800 | 99,267 | 101,144 | 0 | 0 | 0 | 0 | 26,178 | 29,530 | 28,928 | 31,916 | 0 | 0 | 0 | 0 |
| o/w BBA Gross of reinsurance | 50,917 | 52,713 | 52,731 | 46,724 | 9,606 | 10,019 | 9,848 | 8,873 | 13,770 | 14,107 | 16,752 | 14,106 | 1,670 | 1,659 | 1,522 | 1,473 | 25,871 | 26,927 | 24,608 | 22,272 | 0 | 0 | 0 | 0 |
| o/w Reinsurance | -18,679 | -18,595 | -17,381 | -16,770 | -12,790 | -12,682 | -12,093 | -11,715 | -108 | -66 | 39 | 183 | -1,346 | -1,315 | -1,212 | -1,164 | -4,435 | -4,532 | -4,116 | -4,074 | 0 | 0 | 0 | 0 |
10. Health UE by Geography
| EUR million | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | Transversal & Other | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 5,867 | 11,960 | 6,301 | 12,972 | 2,752 | 5,661 | 2,865 | 5,744 | 1,725 | 3,495 | 1,997 | 4,314 | 0 | 0 | 0 | 0 | 1,300 | 2,629 | 1,350 | 2,742 | 90 | 174 | 88 | 172 |
| Combined Ratio | 98.6% | 98.1% | 97.8% | 97.9% | 97.8% | 97.9% | 98.5% | 98.1% | 99.4% | 97.5% | 96.9% | 95.2% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 98.3% | 102.3% | 92.2% | 89.1% | 83.6% | 86.7% |
| Technical Margin | 79 | 224 | 141 | 273 | 62 | 117 | 42 | 108 | 10 | 88 | 62 | 206 | 0 | 0 | 0 | 0 | 1 | 1 | 23 | -64 | 7 | 19 | 14 | 23 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 259 | 522 | 270 | 539 | 0 | 0 | 0 | 0 | 78 | 161 | 84 | 180 | 0 | 0 | 0 | 0 | 180 | 360 | 186 | 359 | 0 | 0 | 0 | 0 |
| Technical Experience | 7 | 3 | -2 | -11 | 0 | 0 | 0 | 0 | -6 | -20 | -5 | -17 | 0 | 0 | 0 | 0 | 14 | 23 | 3 | 6 | 0 | 0 | 0 | 0 |
| Actual vs. Expected Cash Flows | 13 | 18 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 18 | 2 | 2 | 0 | 0 | 0 | 0 |
| Risk Adjustment Release | 4 | 8 | 7 | 13 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 3 | 0 | 0 | 0 | 0 | 5 | 10 | 5 | 11 | 0 | 0 | 0 | 0 |
| Changes in Onerous Contracts | -1 | -2 | -2 | -4 | 0 | 0 | 0 | 0 | -1 | -2 | 0 | -3 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| Other Long-term | -8 | -21 | -9 | -22 | 0 | 0 | 0 | 0 | -6 | -16 | -6 | -16 | 0 | 0 | 0 | 0 | -2 | -5 | -3 | -5 | 0 | 0 | 0 | 0 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 82 | 176 | 101 | 209 | -3 | -1 | 4 | 12 | 35 | 72 | 37 | 76 | 0 | 0 | 0 | 0 | 51 | 105 | 60 | 118 | 0 | 0 | 0 | 2 |
| Investment Income | 160 | 317 | 170 | 341 | 26 | 41 | 24 | 55 | 39 | 77 | 40 | 79 | 0 | 0 | 0 | 0 | 95 | 198 | 106 | 205 | 0 | 0 | 0 | 2 |
| Insurance Finance Expenses | -78 | -140 | -69 | -133 | -29 | -43 | -20 | -42 | -4 | -5 | -4 | -3 | 0 | 0 | 0 | 0 | -45 | -93 | -45 | -87 | 0 | 0 | 0 | 0 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 427 | 925 | 510 | 1,010 | 59 | 116 | 46 | 120 | 117 | 302 | 178 | 446 | 0 | 0 | 0 | 0 | 245 | 489 | 272 | 419 | 7 | 19 | 14 | 25 |
| Tax | -96 | -239 | -133 | -216 | -10 | -27 | -7 | -24 | -31 | -87 | -46 | -101 | 0 | 0 | 0 | 0 | -55 | -125 | -80 | -88 | 0 | 0 | -1 | -4 |
| Income from Affiliates & Other | 2 | 4 | 8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 8 | 2 | 0 | 0 | 0 | 0 |
| Minority Interests | 0 | -4 | -3 | -9 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | -3 | -3 | -6 | 0 | 0 | 0 | 0 |
| Underlying Earnings Group share | 333 | 687 | 381 | 787 | 49 | 89 | 39 | 96 | 85 | 213 | 132 | 341 | 0 | 0 | 0 | 0 | 192 | 366 | 197 | 328 | 7 | 19 | 14 | 22 |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 2,289 | 2,000 | 2,750 | 2,490 | 27 | 18 | 24 | 35 | 1,231 | 981 | 1,654 | 1,375 | 0 | 0 | 0 | 0 | 1,022 | 995 | 1,067 | 1,069 | 9 | 6 | 5 | 10 |
| Best Estimate for incurred Claims net of reinsurance | 2,286 | 2,384 | 2,337 | 3,386 | 1,240 | 1,329 | 1,091 | 1,911 | 698 | 751 | 898 | 1,062 | 0 | 0 | 0 | 0 | 336 | 290 | 334 | 398 | 13 | 14 | 15 | 15 |
| For long-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Best Estimate Liabilities net of reinsurance | 20,066 | 20,858 | 20,726 | 20,112 | 0 | 0 | 0 | 0 | 20,645 | 21,416 | 21,527 | 21,291 | 0 | 0 | 0 | 0 | -579 | -557 | -800 | -1,180 | 0 | 0 | 0 | 0 |
| o/w VFA Gross of reinsurance | 20,977 | 21,821 | 21,996 | 21,576 | 0 | 0 | 0 | 0 | 20,896 | 21,713 | 21,868 | 21,637 | 0 | 0 | 0 | 0 | 81 | 109 | 128 | -62 | 0 | 0 | 0 | 0 |
| o/w BBA Gross of reinsurance | -821 | -868 | -1,207 | -1,417 | 0 | 0 | 0 | 0 | -250 | -297 | -342 | -346 | 0 | 0 | 0 | 0 | -571 | -571 | -866 | -1,071 | 0 | 0 | 0 | 0 |
| o/w Reinsurance | -90 | -95 | -62 | -47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -90 | -95 | -62 | -47 | 0 | 0 | 0 | 0 |
11. Asset Management
| EUR million | 1H24 | FY24 | 1H25 | FY25* | ||||
|---|---|---|---|---|---|---|---|---|
| — | Total | o/w Third Party | Total | o/w Third Party | Total | o/w Third Party | Total | o/w Third Party |
| Opening AUM (in Euro billion) | 843 | 332 | 843 | 332 | 879 | 356 | 879 | 356 |
| Net Inflows | 7 | -1 | 3 | 4 | -3 | -10 | -3 | -10 |
| Scope & Other | 0 | 10 | 2 | 21 | 0 | -6 | 0 | -6 |
| Market Effect | 12 | 10 | 26 | 21 | -3 | -6 | -3 | -6 |
| Currency Impact | -4 | 10 | 5 | 21 | -21 | -6 | -21 | -6 |
| Closing AUM (in Euro billion) | 859 | 340 | 879 | 356 | 853 | 341 | 853 | 341 |
| Alternatives | 227 | 86 | 229 | 90 | 233 | 95 | 233 | 95 |
| Core & Other | 532 | 254 | 551 | 266 | 528 | 246 | 528 | 246 |
| Asian Joint Ventures | 101 | — | 99 | — | 92 | — | 92 | — |
| Gross Revenues - After Intercompany Elimination | 787 | — | 1,701 | — | 875 | — | 875 | — |
| Gross Revenues - Before Intercompany Elimination | 937 | — | 2,004 | — | 1,018 | — | 1,018 | — |
| Management Fees | 679 | 385 | 1,425 | 773 | 724 | 439 | 724 | 439 |
| Performance Fees | 18 | 8 | 57 | 21 | 16 | 9 | 16 | 9 |
| Distribution Fees | 205 | — | 409 | — | 231 | — | 231 | — |
| Other | 35 | — | 112 | — | 46 | — | 46 | — |
| General Expenses | -698 | — | -1,493 | — | -793 | — | -793 | — |
| Distribution Fees Retroceded | -205 | — | -409 | — | -231 | — | -231 | — |
| Financial Result | 24 | — | 35 | — | 14 | — | 14 | — |
| Underlying Earnings Before Tax | 263 | — | 546 | — | 239 | — | 239 | — |
| Tax | -69 | — | -160 | — | -68 | — | -68 | — |
| Income from Affiliates & Other | 16 | — | 29 | — | 8 | — | 8 | — |
| Minority Interests | -6 | — | -13 | — | -4 | — | -4 | — |
| Underlying Earnings Group Share | 204 | — | 402 | — | 175 | — | 175 | — |
| Average Assets under Management (€bn) | 749 | — | 759 | — | 769 | — | 769 | — |
| Asset Management Fee bps | 18.1 bps | — | 18.8 bps | — | 18.8 bps | — | 18.8 bps | — |
| Underlying Cost Income Ratio | 67.3% | — | 68.0% | — | 71.4% | — | 71.4% | — |
- (*) AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.
12. Holdings
| EUR million | 1H24 | FY24 | 1H25 | FY25 |
|---|---|---|---|---|
| Financial Result | 181 | 402 | 228 | 422 |
| Other Revenues | 522 | 1,050 | 607 | 1,149 |
| Other Expenses | -925 | -1,986 | -1,075 | -2,107 |
| Debt Financing Charges | -471 | -948 | -452 | -928 |
| Underlying Earnings Before Tax | -693 | -1,482 | -692 | -1,464 |
| Tax | 100 | 324 | 101 | 284 |
| Income from Affiliates & Other | 0 | 0 | 0 | 0 |
| Minority Interests | 0 | 0 | 0 | 0 |
| Underlying Earnings Group share | -592 | -1,157 | -591 | -1,180 |
- ¹ Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.
- ² Includes liquid invested assets.
- ³ Includes exceptional cash remittances from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.4 billion in 2024) and AXA Life Europe (Euro +0.2 billion in 2024).
- ⁴ On top of annual share buy-back, includes Euro +3.5 billion share buy-back in 2025 to offset the earnings dilution resulting from the disposal of AXA IM and Euro +0.7 billion share buy-back in 2024 from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.5 billion) and AXA Life Europe (Euro +0.2 billion).
13. Activity indicators
| EUR million | 1H24 | FY24 | 1H25 | FY25 | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | Total | P&C | Life & Health | o/w Employee Benefits | Life | Health | Asset Management | Bank | Total | P&C | Life & Health | o/w Employee Benefits | Life | Health | Asset Management | Bank | Total | P&C | Life & Health | o/w Employee Benefits | Life | Health | Asset Management | Bank | Total | P&C | Life & Health | o/w Employee Benefits | Life | Health | Asset Management | Bank |
| Gross Written Premiums & Other Revenues | 59,872 | 32,522 | 26,505 | 6,673 | 17,419 | 9,086 | 787 | 57 | 110,316 | 56,514 | 51,983 | 12,167 | 34,497 | 17,486 | 1,701 | 118 | 64,251 | 34,097 | 29,230 | 7,223 | 19,081 | 10,149 | 875 | 49 | 115,524 | 58,038 | 56,512 | 12,867 | 37,499 | 19,014 | 875 | 99 |
| IFRS17/9 New Business Value (NBV) (a) | 1,206 | — | 1,206 | — | 953 | 253 | — | — | 2,264 | — | 2,264 | — | 1,792 | 473 | — | — | 1,189 | — | 1,189 | — | 928 | 260 | — | — | 2,233 | — | 2,233 | — | 1,747 | 486 | — | — |
| New Business Contractual Service Margin (NB CSM) | 1,131 | — | 1,131 | — | 919 | 213 | — | — | 2,169 | — | 2,169 | — | 1,770 | 399 | — | — | 1,184 | — | 1,184 | — | 950 | 234 | — | — | 2,199 | — | 2,199 | — | 1,822 | 377 | — | — |
| Other NBV * | 456 | — | 456 | — | 333 | 123 | — | — | 824 | — | 824 | — | 594 | 231 | — | — | 382 | — | 382 | — | 270 | 113 | — | — | 757 | — | 757 | — | 491 | 266 | — | — |
| Tax | -381 | — | -381 | — | -299 | -83 | — | — | -729 | — | -729 | — | -572 | -158 | — | — | -378 | — | -378 | — | -292 | -86 | — | — | -724 | — | -724 | — | -567 | -157 | — | — |
| Present Value of Expected Premiums (PVEP) (b) | 25,588 | — | 25,588 | — | 18,234 | 7,354 | — | — | 50,896 | — | 50,896 | — | 36,860 | 14,036 | — | — | 25,918 | — | 25,918 | — | 19,487 | 6,430 | — | — | 49,357 | — | 49,357 | — | 37,103 | 12,254 | — | — |
| IFRS17/9 NBV Margin (a)/(b) | 4.7% | — | 4.7% | — | 5.2% | 3.4% | — | — | 4.4% | — | 4.4% | — | 4.9% | 3.4% | — | — | 4.6% | — | 4.6% | — | 4.8% | 4.0% | — | — | 4.5% | — | 4.5% | — | 4.7% | 4.0% | — | — |
| EUR million | 1H24 | FY24 | 1H25 | FY25 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM | Transversal & Other | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM | Transversal & Other | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM | Transversal & Other | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM | Transversal & Other |
| Gross Written Premiums & Other Revenues | 59,872 | 14,719 | 22,579 | 11,220 | 9,571 | 787 | 995 | 110,316 | 28,996 | 39,298 | 19,383 | 19,083 | 1,701 | 1,856 | 64,251 | 15,670 | 24,649 | 11,749 | 10,302 | 875 | 1,006 | 115,524 | 30,598 | 43,005 | 19,277 | 19,925 | 875 | 1,844 |
| IFRS17/9 New Business Value (NBV) (a) | 1,206 | 354 | 348 | — | 504 | — | — | 2,264 | 682 | 597 | — | 986 | — | — | 1,189 | 315 | 364 | — | 510 | — | — | 2,233 | 695 | 578 | — | 959 | — | — |
| New Business Contractual Service Margin (NB CSM) | 1,131 | 203 | 398 | — | 531 | — | — | 2,169 | 391 | 731 | — | 1,047 | — | — | 1,184 | 199 | 443 | — | 541 | — | — | 2,199 | 431 | 740 | — | 1,028 | — | — |
| Other NBV * | 456 | 275 | 50 | — | 131 | — | — | 824 | 528 | 49 | — | 247 | — | — | 382 | 225 | 28 | — | 129 | — | — | 757 | 506 | 12 | — | 239 | — | — |
| Tax | -381 | -123 | -100 | — | -158 | — | — | -729 | -237 | -184 | — | -309 | — | — | -378 | -109 | -107 | — | -161 | — | — | -724 | -242 | -174 | — | -308 | — | — |
| Present Value of Expected Premiums (PVEP) (b) | 25,588 | 12,301 | 6,317 | — | 6,971 | — | — | 50,896 | 25,370 | 11,831 | — | 13,695 | — | — | 25,918 | 11,662 | 6,843 | — | 7,413 | — | — | 49,357 | 22,858 | 12,651 | — | 13,847 | — | — |
| IFRS17/9 NBV Margin (a)/(b) | 4.7% | 2.9% | 5.5% | — | 7.2% | — | — | 4.4% | 2.7% | 5.0% | — | 7.2% | — | — | 4.6% | 2.7% | 5.3% | — | 6.9% | — | — | 4.5% | 3.0% | 4.6% | — | 6.9% | — | — |
- (*) Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers.
- (**) Employee Benefits include Group Protection and Group Health contracts.
14. Balance Sheet
| EUR billion | FY24 | FY25 |
|---|---|---|
| Goodwill | 18.1 | 17.8 |
| Other intangible assets | 4.4 | 4.4 |
| Total Intangible assets | 22.6 | 22.2 |
| Investments in real estate properties | 29.2 | 27.8 |
| Financial investments | 418.2 | 401.8 |
| Unit-linked Assets | 90.1 | 97.2 |
| Total Investments from Insurance activities | 537.5 | 526.9 |
| Investments from Non-Insurance Activities | 18.5 | 16.6 |
| Equity Method investments | 1.5 | 1.5 |
| Assets Arising from Insurance and Reinsurance Contracts Held | 26.1 | 23.9 |
| Present Value of Future Cash Flows | 24.1 | 22.0 |
| Contractual Service Margin | 1.4 | 1.4 |
| Risk Adjustment | 0.5 | 0.5 |
| Receivables and Other Assets | 24.1 | 21.9 |
| Assets held for sale | 4.5 | 0.2 |
| Cash and cash equivalents | 19.0 | 22.2 |
| Total Assets | 653.8 | 635.5 |
| EUR billion | FY24 | FY25 |
|---|---|---|
| Shareholders' Equity group share | 49.9 | 47.2 |
| Non-controlling Interests | 2.5 | 2.4 |
| Shareholders’ equity | 52.5 | 49.6 |
| Financing debt | 14.4 | 15.8 |
| Liabilities arising from insurance contracts and investment contracts with discretionary participation features contracts | 477.0 | 470.4 |
| Present Value of Future Cash Flows | 438.4 | 432.6 |
| Contractual Service Margin | 35.3 | 34.7 |
| Risk Adjustment | 3.3 | 3.1 |
| Other Investment Contract Liabilities | 12.6 | 12.8 |
| Liabilities arising from insurance, reinsurance and investment contracts | 489.6 | 483.2 |
| Liabilities Arising from Non-Insurance Activities | 10.1 | 9.9 |
| Provisions for risks and charges | 4.9 | 4.6 |
| Payables and Other liabilities | 80.9 | 72.5 |
| Liabilities held for sale | 1.4 | 0.0 |
| Total Liabilities, Non-controlling Interests and Shareholders' Equity | 653.8 | 635.5 |
15.CSM Rollforward
| EUR million | FY23 Restated | New Business CSM | Underlying Return on inforce | CSM Release | Economic Variance | Operating Variance | Other* | FY24 |
|---|---|---|---|---|---|---|---|---|
| Total Group (pre-tax) | 34,187 | 2,169 | 1,383 | -2,775 | -998 | 432 | -545 | 33,853 |
| P&C | 206 | 0 | 0 | 0 | 0 | 0 | 76 | 282 |
| Life | 26,200 | 1,770 | 1,172 | -2,253 | -890 | 363 | -534 | 25,826 |
| Health | 7,782 | 400 | 211 | -522 | -108 | 69 | -87 | 7,744 |
| Total Group (post-tax) | 26,777 | — | — | — | — | — | — | 26,320 |
- (*) Including scope changes and FX. ** Following the termination of the sale of a closed life and pensions portfolio at AXA Germany in 2024. It was classified as held for sale in 2023.
| EUR million | FY24 | New Business CSM | Underlying Return on inforce | CSM Release | Economic Variance | Operating Variance | Other* | FY25 |
|---|---|---|---|---|---|---|---|---|
| Total Group (pre-tax) | 33,853 | 2,199 | 1,328 | -2,954 | 594 | -316 | -1,451 | 33,253 |
| P&C | 282 | 0 | 0 | 0 | 0 | 0 | -21 | 261 |
| Life | 25,826 | 1,822 | 1,150 | -2,415 | 487 | -526 | -903 | 25,442 |
| Health | 7,744 | 377 | 178 | -539 | 107 | 210 | -527 | 7,550 |
| Total Group (post-tax) | 26,320 | — | — | — | — | — | — | 25,864 |
- (*) Including scope changes and FX.
16. Invested Assets
| EUR billion | Fair value | Asset Allocation % | o/w Participating |
|---|---|---|---|
| General Account Invested Assets1 | 450 | — | 60% |
| Fixed Income | 345 | 77% | 60% |
| Government Bonds | 167 | 37% | 66% |
| Corporate Bonds and Loans | 121 | 27% | 55% |
| Other Fixed Income | 56 | 13% | 52% |
| Asset Backed Securities | 25 | 6% | 48% |
| Mortgage Loans | 31 | 7% | 56% |
| Real Estate | 41 | 9% | 63% |
| Infrastructure Equity | 10 | 2% | 64% |
| Listed Equities | 10 | 2% | 82% |
| Private Equity & Hedge Funds | 23 | 5% | 55% |
| Cash | 19 | 4% | 50% |
| Policy Loans | 2 | 0% | 51% |
- 1 Reflects the fair value of assets excluding the minority interest share in assets held in fully consolidated invested funds, hedging derivatives, Unit-linked assets and investments from non-insurance activities.
- 1 Corporate bonds not rated by external rating agencies are reallocated under AXA’s internal ratings: AAA: Euro 0.03billion, AA: Euro 1billion, A: Euro 1,2 billion, BBB: Euro 3.6 billion, Below investment grade: Euro 5 billion.
- 2 Includes 91% of CLOs.
- 3 Residential loans (Euro 16 billion), Agency Pools (Euro 8 billion), and Commercial & agricultural loans (Euro 7 billion).
- 4 Includes hedges. Listed equities excluding hedges at Euro 14 billion (basis for % of participating).
- 5 Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).
| EUR billion | Fair Value by Rating | ||||||
|---|---|---|---|---|---|---|---|
| — | Average rating | AAA | AA | A | BBB | Below Investment Grade | Non Rated |
| -0.4 yr | — | — | — | — | — | — | — |
| — | AA | 27% | 31% | 28% | 10% | 2% | 2% |
| — | A | 16% | 6% | 39% | 28% | 11% | — |
| — | — | 54% | 28% | 10% | 3% | 1% | 4% |
17. Supplementary Info on Asset
| EUR billion | Fair Value | Belgium | France | Germany | Italy | Japan | Netherlands | Spain | Switzerland | United States | Other EU countries | Supranational | Rest of the World |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Geographical Exposure | 167 | 6% | 12% | 6% | 5% | 8% | 3% | 6% | 9% | 10% | 8% | 13% | 15% |
- Corporate Bonds and Loans
| EUR billion | Fair Value | Basic Materials | Communications | Consumer, Cyclical | Consumer, Non-Cyclical | Covered and Senior Secured Bonds | Energy | Financials | Industrial | Technology | Utilities | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Industry | 121 | 2% | 6% | 4% | 11% | 29% | 1% | 28% | 6% | 2% | 8% | 3% |
| EUR billion | Total | Banks | Non-Banks |
|---|---|---|---|
| Total | 33.4 | 27.5 | 6.0 |
| Senior Unsecured Bonds | 29.8 | 24.3 | 5.5 |
| Subordinated Bonds | 3.0 | 2.7 | 0.4 |
| Other | 0.6 | 0.5 | 0.1 |
- 1 Includes REITS corporate bonds (Euro 3 billion).
- 2 Includes AT1 (Euro 0.4 billion).
- Listed Equities1
| EUR billion | Fair Value | Belgium | France | Germany | Japan | Netherlands | Switzerland | United States | Other EU countries | Rest of the World |
|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Asset Domiciliation | 10 | 3% | 7% | 3% | 7% | 2% | 4% | 37% | 9% | 27% |
| EUR billion | Fair Value | Basic Materials | Communications | Consumer, Cyclical | Consumer, Non-Cyclical | Diversified | Energy | Financials | Funds | Industrial | Technology | Utilities | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Industry | 10 | 5% | 11% | 9% | 14% | 3% | 0% | 20% | 6% | 12% | 17% | 1% | 0% |
- 1 Including hedges.
- Real Estate
| EUR billion | Fair Value | Belgium | France | Germany | Italy | Japan | Spain | Switzerland | United Kingdom | United States | Other EU countries | Rest of the World |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Geographical Exposure | 41 | 5% | 25% | 11% | 3% | 5% | 4% | 13% | 7% | 12% | 5% | 10% |
| EUR billion | Fair Value | Office | Residential | Industrial-Logistic | Retail | Others |
|---|---|---|---|---|---|---|
| Breakdown By Type | 41 | 33% | 22% | 15% | 12% | 18% |
- Private Equities1
| EUR billion | Fair Value | Europe | Japan | United States | Other |
|---|---|---|---|---|---|
| Breakdown By Asset Domiciliation | 17 | 45% | 5% | 46% | 5% |
- 1 Excluding Non-listed Equity.
- Mortgage Loans1,2
| EUR billion | Fair Value | Residential | Commercial |
|---|---|---|---|
| Breakdown by Type | 23 | 69% | 31% |
- 1 Excludes banking operations and Euro 8 billion of Agency pools (Mortgage-backed securities issues by US Government Sponsored Enterprises).
- 2 Loan to Value: 46%.
| — | FY25 |
|---|---|
| Shareholders' Equity at Beginning of the Period | 49.9 |
| Paid-in Capital | -4.9 |
| Treasury Shares | -0.1 |
| Other Comprehensive Income Arising from Defined Benefit Plans | -0.3 |
| Fair Value Recorded in Shareholders' Equity | 1.3 |
| Other Comprehensive Income Related to Invested Assets | -4.2 |
| Other Comprehensive Income Related to (re) Insurance Contracts | 5.4 |
| Impact of Currency Fluctuations | -3.5 |
| Undated Subordinated Debt (including interest charges) | -0.3 |
| Realized Gains on Equity through Retained Earnings | 0.1 |
| Dividends | -4.6 |
| Net Income for the Period | 9.8 |
| Other | -0.2 |
| Shareholders' Equity at End of the Period | 47.2 |
| — | FY24 | FY25 |
|---|---|---|
| Paid-in Capital | 21.8 | 16.9 |
| Treasury Shares | -1.5 | -1.6 |
| Other Comprehensive Income Arising from Defined Benefit Plans | -2.4 | -2.8 |
| Other Comprehensive Income | -8.1 | -6.8 |
| Other Comprehensive Income Related to Invested Assets | -13.1 | -17.3 |
| Other Comprehensive Income Related to (re) Insurance Contracts | 5.0 | 10.5 |
| Translation Reserves | -1.1 | -4.6 |
| Undated Subordinated Debt | 4.8 | 4.6 |
| Retained Earnings | 36.5 | 41.4 |
| Total Shareholders' Equity at the End of the Period | 49.9 | 47.2 |
- (a) Shareholders' equity excludes the other comprehensive income as well as the undated and deeply subordinated debt.
- (b) Shareholders' equity excludes the undated and deeply subordinated debt. CSM is net of tax and Group Share.
| — | FY24 | FY25 |
|---|---|---|
| Government Bonds (recyclable) | -7.5 | -13.0 |
| Corporate Bonds (recyclable) | -4.1 | -3.0 |
| Cash Flow hedges (recyclable) | -3.5 | -3.3 |
| Equities (non-recyclable) | 2.3 | 2.1 |
| Others (recyclable) | -0.3 | -0.1 |
| Total Other Comprehensive Income Related to Invested Assets | -13.1 | -17.3 |
| Real Estate | 6.7 | 6.5 |
| Other Invested Assets Not Included in Shareholders' Equity | -0.6 | -0.1 |
| Total Unrealized Gains and Losses on Invested Assets at Cost (Net of Tax) | 6.1 | 6.4 |
| Total Unrealized Gains and Losses on Invested Assets (Net of Tax) | -7.0 | -10.9 |
19. ROE&Gearing
| EUR billion | FY24 | FY25 | Change in % points (FY25 vs FY24) |
|---|---|---|---|
| Net Income ROE | 14.8% | 18.8% | 3.9 pt |
| Net Income (a) | 7.7 | 9.6 | — |
| Average Adjusted Shareholders' Equity (b) | 51.8 | 51.3 | — |
| Underlying ROE | 15.2% | 16.0% | 0.8 pt |
| Underlying Earnings (a) | 7.9 | 8.2 | — |
| Average Adjusted Shareholders' Equity (b) | 51.8 | 51.3 | — |
- (a) Including adjustments to reflect net financial charges related to undated and deeply subordinated debt (recorded through shareholders' equity).
- (b) Excluding reserves for Other Comprehensive Income as well as undated and deeply subordinated debt (recorded through shareholders' equity).
- Financial interest treatment
| EUR billion | FY24 | FY25 |
|---|---|---|
| Financing Debt | 3.2 | 3.2 |
| Financing Debt Instrument Issued | 3.2 | 3.2 |
| Financing Debt Owed to Credit Institutions | 0.0 | 0.0 |
| Dated Subordinated Debt | 11.2 | 12.6 |
| Reversal of mark-to-market of interest rates derivatives | -0.1 | -0.1 |
| Total Gross Debt (A) | 14.3 | 15.7 |
| Undated Deeply Subordinated Notes (TSS) | 2.9 | 4.3 |
| Deeply Subordinated Notes (TSDI) | 1.9 | 0.3 |
| Total Gross Debt incl. Undated and Deeply Subordinated Notes (B) | 19.2 | 20.3 |
| Shareholders' Equity (Including Non-Controlling Interests) (a) (C) | 52.5 | 49.6 |
| Contractual Service Margin net of tax (D) | 26.3 | 25.9 |
| Shareholders' Equity + Contractual Service Margin + Gross Debt (E) = (C) + (D) + (A) | 93.1 | 91.1 |
| Debt Gearing (G) = (B) / (E) | 20.6% | 22.3% |
- (a) Shareholders' equity includes undated and deeply subordinated debts.
20. Information on Solvency II
| EUR billion | FY24 | Regulatory & model changes | Normalized Capital Generation | Operating variance | Economic variance (incl. FX) | Dividend & share buy-backs | Debt | M&A, In-force and Other | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Eligible Own Fund (EOF) | 55.9 | 0.2 | 8.8 | -0.4 | -2.1 | -6.0 | 1.6 | -1.7 | 56.4 |
| Solvency Capital Requirement (SCR) | 25.9 | 0.0 | 0.6 | 0.0 | -1.2 | 0.0 | 0.0 | -0.2 | 25.2 |
| Solvency II Ratio | 216% | 0% | 28% | -1% | 4% | -24% | 6% | -5% | 224% |
| EUR billion | Total | Unrestricted Tier | Restricted Tier | Tier | |
|---|---|---|---|---|---|
| EOF as of FY25 | 56.4 | 39.6 | 4.7 | 11.6 | 0.4 |
| Insurance Sector | 55.1 | 38.4 | 4.7 | 11.6 | 0.4 |
| Ancillary | — | — | — | — | — |
| Subject to Transitional Measures* | 2.4 | — | 1.4 | 1.0 | — |
| Other Financial Sectors | 1.2 | 1.2 | — | — | — |
| EOF as of FY24 | 55.9 | 40.0 | 4.9 | 10.2 | 0.8 |
| Insurance Sector | 53.5 | 37.5 | 4.9 | 10.2 | 0.8 |
| Ancillary | — | — | — | — | — |
| Subject to Transitional Measures* | 4.5 | — | 3.4 | 1.1 | — |
| Other Financial Sectors | 2.5 | 2.5 | — | — | — |
- (*) Transitional measures on basic own funds applied on subordinated debts eligible under Solvency I regulation. These subordinated debts were also eligible under Solvency II until December 31, 2025. They are no longer eligible since January 1, 2026.
| EUR billion | FY24 | FY25 |
|---|---|---|
| Interest Rate +50 bps | +2 pts | +2 pts |
| Interest Rate -50 bps | -4 pts | -1 pt |
| Corporate Spread +50bps | -1 pt | -1 pt |
| Euro Government Spreads +50bps | -10 pts | -7 pts |
| Credit Migration +20% | -4 pts | -4 pts |
| Listed Equities +25% | +0 pt | -1 pt |
| Listed Equities -25% | -3 pts | +2 pts |
| Private and Infrastructure Equity +25% | +13 pts | +14 pts |
| Private and Infrastructure Equity -25% | -15 pts | -19 pts |
| Inflation swap curve +50bps | -6 pts | -5 pts |
21. IFRS17 SHE to Group EOF
| EUR billion | FY25 |
|---|---|
| IFRS SHAREHOLDERS' EQUITY | 49.6 |
| Contractual Service Margin (net of tax) | 25.9 |
| IFRS SHAREHOLDERS' EQUITY inc. CSM | 75.5 |
| Net URCG not included in Shareholders' Equity | 6.4 |
| Elimination Undated Subordinated Debts | -4.6 |
| Elimination Intangibles | -21.3 |
| Goodwill | -17.8 |
| others | -3.5 |
| IFRS TANGIBLE NET ASSET VALUE | 56.0 |
| Foreseeable dividends and distribution | -6.3 |
| Technical provision adjustments | -9.6 |
| Risk Margin vs Risk Adjustment | -6.4 |
| BEL adjustment | -3.2 |
| Other adjustments | -0.6 |
| UNRESTRICTED TIER 1 | 39.6 |
| Restricted Tier 1 + Tier | 16.4 |
| Tier | 0.4 |
| GROUP ELIGIBLE OWN FUNDS | 56.4 |